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Abstract 
This paper provides a review of the types of emerging organic groundwater contaminants 
(EGCs) which are beginning to be found in the UK.  EGCs are compounds being found in 
groundwater that were previously not detectable or known to be significant and can come 
from agricultural, urban and rural point sources. EGCs include nanomaterials, pesticides, 
pharmaceuticals, industrial compounds, personal care products, fragrances, water treatment 
by-products, flame retardants and surfactants, as well as caffeine and nicotine. Many are 
relatively small polar molecules which may not be effectively removed by drinking water 
treatment. Data from the UK Environment Agency’s groundwater screening programme for 
organic pollutants found within the 30 most frequently detected compounds a number of 
EGCs such as pesticide metabolites, caffeine and DEET. Specific determinands frequently 
detected include pesticides metabolites, pharmaceuticals including carbamazepine and 
triclosan, nicotine, food additives and alkyl phosphates. This paper discusses the routes by 
which these compounds enter groundwater, their toxicity and potential risks to drinking water 
and the environment. It identifies challenges that need to be met to minimise risk to drinking 
water and ecosystems. 
Keywords 
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1 Introduction 
The term emerging groundwater contaminants (EGCs) is generally used to refer to 
compounds previously not considered or known to be significant in groundwater in terms of 
distribution and/or concentration, which are now being more widely detected and which have 
the potential  to cause  known or suspected adverse ecological or human health effects. 
Synthesis of new chemicals or changes in use and disposal of existing chemicals can create 
new sources of EGCs. These will also include substances that have long been present in the 
environment but whose presence and significance are only now being elucidated (Daughton, 
2004). As analytical techniques improve, previously undetected organic micro-contaminants 
are being observed in the aqueous environment, e.g. metaldehyde. Richardson and Ternes 
(2011) review recent analytical developments in the emerging contaminant context. 
EGCs are commonly derived from a variety of municipal, agricultural, and industrial sources 
and pathways.  Many have remained unidentified presumably due to similar reasons to 
current, well-established problems. For example, Jackson (2004) ascribes the historical lack 
of recognition of chlorinated solvent contamination and its subsequent emergence to the lack 
of a technical paradigm explaining the processes of contamination and the identification of 
adverse effects.  
Many EGCs remain unregulated and Kavanaugh (2003) set out the technical and institutional 
challenges presented by unregulated contaminants. The number of regulated contaminants 
will continue to grow slowly over the coming decades. In the European context groundwater 
quality is currently regulated under the Water Framework Directive and the Groundwater 
Daughter Directive and drinking water under the Drinking Water Directive. Pesticides are 
also regulated under the Plant Protection and Biocides Directives. Some of these 
contaminants can have human or ecological health effects and there is a need for better 
understanding of their fate in environmental systems.  
The European Drinking Water Directive sets limits for a small number of organic 
micropollutants comprising aromatic hydrocarbons, chlorinated solvents and disinfection by-
products (EC, 1998).  The Priority Substances Directive establishes a number of Priority 
Substances, including benzene, octyl and nonyl phenols, specified polyaromatic 
hydrocarbons (PAH), di(2-ethylhexyl)phthalate and a range of chlorinated hydrocarbons (EC, 
2008). Proposed revisions include the emerging contaminants ibuprofen, diclofenac, α-
ethinyloestradiol, -oestradiol and perfluorooctane sulfonate (PFOS) (EC, 2011). 
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The US EPA have derived statutory guideline values for about 125 contaminants in drinking 
water of which 31 could be considered to be micro-organic pollutants excluding pesticides. 
None of these are pharmaceuticals or personal care products (PCP) (US EPA, 2010). 
Most emerging contaminant research has focussed on surface waters as these are likely to 
contain greater concentrations of contaminants from sources such as wastewater treatment 
works’ (WTWs) discharges. Surface water is also easier to monitor than groundwater in some 
respects. The approach taken in this review is that surface water data can be used to give us 
an idea of potential future groundwater problems and can provide an early warning. 
This paper provides a review of the types of EGCs which are beginning to be found in 
groundwater of the UK. This is drawn primarily from UK and European studies, 
supplemented by work from the US. It discusses the routes by which these compounds enter 
groundwater, including resistance to wastewater treatment, their toxicity and the consequent 
potential risks posed to drinking water and the environment. This provides the context to a 
UK groundwater monitoring dataset. Challenges that need to be met to minimise risk are 
identified. 
2 Types of emerging groundwater contaminants 
From their sources, physical and chemical characteristics, mobility/behaviour in the aqueous 
environment and associated hazards the following types of micro-contaminants may be 
considered to be emerging in groundwater.  The world-wide occurrence, sources and fate of a 
range of EGCs, including pharmaceuticals and personal care compounds in groundwater has 
been reviewed by Lapworth et al. (submitted).  
Much more is known about pesticides in groundwater compared to other compounds, such as 
pharmaceuticals, which are more poorly characterised.  The hazards to human health of some 
compounds are well documented, but their ability to travel through the aqueous environment 
is only just being investigated, and environmental persistence is as yet unknown. 
2.1 Pesticides 
Pesticides have been detected at trace concentrations in UK groundwater for a considerable 
period.  As those compounds which pose the greatest threat to the environment are gradually 
withdrawn, e.g. atrazine in 1993, the compounds which are substituted can in turn lead to 
problems, e.g. diuron which is itself now banned. A number of compounds have recently 
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caused problems as analytical methods have improved, for example metaldehyde (Bristol 
Water, 30/1/2009; Environment Agency, Jan 2010; Water UK, 2009). Attention has now also 
turned to pesticide metabolites, also termed degradates and reaction products (Kolpin et al., 
1998). By their nature these compounds are biologically active and many may be toxic and 
such data forms part of the pesticide registration process. Studies have shown that pesticide 
metabolites are often detected in groundwater at higher concentrations compared to parent 
compounds from both agricultural and amenity use (Kolpin et al., 2004; Lapworth and 
Gooddy, 2006). 
2.2 Pharmaceuticals 
The presence of pharmaceutical chemicals in the aquatic environment has long been 
recognised as a concern (Richardson and Bowron, 1985). The primary routes for 
pharmaceuticals into the environment are through human excretion, disposal of unused 
products and through agricultural usage (Poynton and Vulpe, 2009). A wide range of 
pharmaceutical products have been detected in surface and groundwater, associated with 
wastewater disposal (Barnes et al., 2008; Miller and Meek, 2006; Nikolaou et al., 2007; Pérez 
and Barceló, 2007; Ternes and Hirsch, 2000; Vulliet and Cren-Olivé, 2011; Watkinson et al., 
2009). These have included: 
 veterinary and human antibiotics: e.g. ciprofloxacin, erythromycin, lincomycin, 
sulfamethoxazole, tetracycline 
 other prescription drugs: codeine, salbutamol, carbamazepine 
 non prescription drugs: acetaminophen (paracetamol), ibuprofen, salicylic acid 
 iodinated X-ray contrast media: iopromide, iopamidol 
Other potential threats to surface water which have been identified are tamiflu and 
chemotherapy drugs, such as 5-fluorourcil, ifosfamide or cyclophosphamide (Buerge et al., 
2006; Johnson et al., 2008; Moldovan, 2006; Singer et al., 2007) and illicit drugs such as 
cocaine and amphetamines (Kasprzyk-Hordern et al., 2008; Zuccato et al., 2008).  
2.3  “Life-style compounds” 
Caffeine and nicotine, and the nicotine metabolite cotinine, are widely detected in 
groundwater impacted by sewage effluent (Godfrey et al., 2007; Seiler et al., 1999; Teijon et 
al., 2010). Van Stempvoort et al. (2011) found high concentrations of the artificial sweeteners 
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acesulfame, saccharine, cyclamate and sucralose in groundwater impacted by sewage 
infiltration ponds and Buerge et al. (2009) showed acesulfame to be widely detected in the 
aquatic environment due to its use, mobility and persistence.  
2.4 Personal care 
Personal care compounds are commonly transmitted to the aqueous environment through 
WTWs. These have included: 
 DEET – N,N-diethyl-meta-toluamide, the most common active ingredient in insect 
repellents 
 parabens – alkyl esters of p-hydroxybenzoic acid, used since the 1930s as 
bacteriostatic and fungistatic agents in drugs, cosmetics, and foods 
 bacteriocide and antifungal agents  – triclosan is widely used in household products, 
such as toothpaste, soap and anti-microbial sprays 
 polycyclic musks – tonalide and galaxolide are used as fragrances in a wide range of 
washing and cleaning agents and personal care products 
 UV filters/sunscreen – organic filters include the benzophenones and 
methoxycinnamates 
Lindström et al. (2002) detected triclosan and its metabolite methyl triclosan in surface water 
in Switzerland and considered the metabolite to be persistent.  
Tonalide (AHTN), galaxolide (HHCB) and HHCB-lactone have been detected in WTW 
effluents (Horii et al., 2007). These compounds have been used as markers for wastewater in 
surface water (Buerge et al., 2003; Fromme et al., 2001). Heberer (2002a) discusses the 
results from investigations of synthetic musk concentrations found in sewage, sewage sludge, 
surface water, aquatic sediment, and biota samples in terms of bioaccumulation, metabolism 
in fish, and environmental and human risk assessment. 
The majority of compounds used as sun screens are lipophilic, conjugated aromatic 
compounds, but are detected in the aqueous environment (Jeon et al., 2006).  
2.5 Industrial additives and by-products 
There are a wide range of industrial compounds which can be released to the environment. 
Many of these have led to well-established problems, such as the chlorinated solvents, 
petroleum hydrocarbons, including the polyaromatic hydrocarbons and the fuel oxygenate 
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methyl tertiary-butyl ether, and plasticisers/resins bisphenols, adipates and phthalates (Garrett 
et al., 1986; Moran et al., 2005; Moran et al., 2006; Verliefde et al., 2007). Most of these 
industrial compounds are classed as priority pollutants or now have drinking water limits and 
as such are not emerging contaminants. However, some breakdown products may be regarded 
as emerging contaminants.  
Industrial EGCs may include:  
 1,4-dioxane, a stabiliser used with 1,1,1,-trichloroethane which is highly soluble in 
groundwater, resistant to naturally occurring biodegradation processes., does not 
readily bind to soils, and readily leaches to groundwater (Abe, 1999).  In 2008, 
testing, sponsored by an independent consumers organization, found 1,4-dioxane in 
almost half of tested personal-care products.  
 Benzotriazole derivatives which are found in pharmaceuticals such as antifungal, 
antibacterial, and antihelmintic drugs. Benzotriazoles are persistent in the aqueous 
environment (Giger et al., 2006; Voutsa et al., 2006). 
 Dioxins can be produced as a consequence of degradation of other micropollutants 
e.g. from the antimicrobial additive triclosan (ENDS, 2010; Mezcua et al., 2004). 
2.6 Food additives 
Triethyl citrate is used as a food additive to stabilise foams, e.g. egg white, and is also used in 
pharmaceutical coatings and as a plasticiser. Butylated hydroxyanisole (BHA) and butylated 
hydroxytoluene (BHT) are used to prevent fat spoilage in foods. Other food additives include 
camphor, 1,8-cineole (eucalyptol), citral, citronellal, cis-3-hexenol, heliotropin, hexanoic 
acid, menthol, phenylethyl alcohol, triacetin, and terpineol. Some of these may be implicated 
as oxidants or endocrine disruptors (Jobling et al., 1995). 
2.7 Water treatment by-products 
The trihalomethanes and haloacetic acids are well established by-products of water 
disinfection (Boorman, 1999). More recent concern has focused on N-nitrosodimethylamine 
(NDMA) as a drinking water contaminant resulting from reactions occurring during 
chlorination or via direct industrial contamination. Because of the relatively high 
concentrations of this the potent carcinogen formed during wastewater chlorination, the 
intentional and unintentional reuse of municipal wastewater is a particularly important area 
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(Mitch et al., 2003). Richardson (2003) found that the change from disinfection with chlorine 
to ozone and chloramines can increase levels of other potentially toxic by-products, e.g. 
bromo- and iodo- THMs and brominated MX (3-chloro-4-dichloromethyl)-5-hydroxy-2(5H)-
furanone). Other by products of water treatment can include polyacrylamide and 
epichlohydrin.  
2.8 Flame/fire retardants 
Polybrominated diphenyl ether flame retardants are extensively used in resins for household 
and industrial use (Rahman et al., 2001) and may enter the environment via waste disposal to 
landfill and incineration. Phosphate-based retardants such tris-(2-chloroethyl) phosphate 
(TRCP) appear to work by forming a non-flammable barrier (Weil et al., 1996) are used in 
industrial and consumer products.  
2.9 Surfactants 
The priority pollutants octyl- and nonyl-phenol (OP and NP) are used in the production of 
alkyl phenol ethoxylates (APEs) which are used in the manufacture of surfactants. Both the 
parent ethoxylates and their metabolites, alkyl phenols and carboxylic degradation products, 
persist in the aquatic environment (Montgomery-Brown and Reinhard, 2003; Soares et al., 
2008).  
Perfluorinated sulfonates and carboxylic acids including perfluorooctane sulfonate (PFOS) 
and perfluorooctanoic acid (PFOA) have been used for over 50 years in food packaging and 
cookware coatings, paints and surfactants cosmetics and fire-fighting foams with consequent 
entry to the environment by run-off from sites of major fires (e.g. Buncefield, UK). They are 
found in WTW effluents and surface water and are very persistent in the environment 
(Ahrens et al., 2009; Poynton and Vulpe, 2009). Harada et al. (2003) showed PFOS to be 
present in sewage effluent in Japan and it has been detected in surface water in Japan (Harada 
et al., 2003; Saito et al., 2003). 
Siloxanes are used in many personal care products and industrial coatings and there is 
concern about potential toxicity and transport into the environment (Richardson, 2007). 
2.10 Hormones and sterols 
Sex hormones include androgens, such as androstenedione and testosterone, and oestrogens 
such as oestrone, oestriol, 17α- and 17β-oestrodiol, and progesterone. There are also synthetic 
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androgens such as oxandrolone, nandrolone and more importantly synthetic oestrogens 
(xenoestrogens) such as 17α-ethinyl oestrodiol and diethylstilbestrol, used as contraceptives. 
Some of these compounds are commonly present in wastewater and WTW effluent (Johnson 
et al., 2000; Standley et al., 2008; Vulliet and Cren-Olivé, 2011).  
A related group of compounds are cholesterol and its metabolite 5β-coprostanol, and the 
plant sterols stigmastanol, stigmasterol and β-sitosterol. Plant sterols (phyto-oestrogens) are 
ingested in edible plants and excreted to wastewater, which may be the largest source of these 
compounds in the environment (Liu et al., 2010).  
2.11 Ionic liquids 
Ionic liquids are salts with low melting point which are being considered as ‘green’ 
replacements for industrial volatile compounds (Thi et al., 2010; Richardson and Ternes, 
2011). These compounds include nitrocyclic rings (e.g. pyridinium, pyrrolidinium, 
morpholinium moieties) and quaternary ammonium salts. Ionic liquids are not yet widely 
used but current formulations have significant water solubility and are likely to be toxic and 
poorly degradable (Thi et al., 2010). 
3 Sources, pathways and receptors  
3.1 Concepts  
Significant risks to human health may result from exposure to non-pathogenic, toxic 
contaminants that are often globally ubiquitous in waters from which drinking water is 
derived.  The transport of contaminants in the aqueous environment can be described by a 
source-pathway-receptor model, which considers:  
 the source of the contaminant, e.g. sewage sludge spread on to agricultural land  
 the pathway by which it travels from the source, e.g. fracture flow through an aquifer  
 the receptor, e.g. a consumer drinking tap water 
Sources of contaminants to surface waters, groundwater, sediments, and drinking water are 
varied and include pesticide applications to agricultural land, horticulture, parks, gardens, 
golf courses, urban infrastructure, and the transport network, discharges or leaks of domestic, 
hospital or industrial wastewater containing pharmaceutical or personal care compounds, 
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sewage sludge application to land, pharmaceuticals and pesticides used to treat animals 
present in manure stores or applied to agricultural land and solid waste disposal. 
Point-source pollution originates from discrete sources whose inputs into aquatic systems can 
often be defined in a spatially explicit manner. Examples of point-source pollution include 
industrial effluents (pulp and paper mills, steel plants, food processing plants), municipal 
WTWs and combined sewage-storm-water overflows, animal waste lagoons, resource 
extraction (mining), and land disposal sites (landfill sites, industrial impoundments).  
Non-point-source pollution, in contrast, originates from poorly defined, diffuse sources that 
typically occur over broad geographical scales. Examples of non-point-source pollution 
include agricultural runoff (pesticides, pathogens, and fertilizers), storm-water and urban 
runoff, and atmospheric deposition (wet and dry deposition of persistent organic pollutants) 
(Bedding et al., 1982; Ritter et al., 2002). About 70% of land area in the UK is used for 
agricultural purposes and about 6% is urban. 
3.2 Source terms 
Potential source terms include wastewater, derived from domestic, industrial, or hospital 
premises and waste disposal sites (Bester et al., 2008; Heberer and Feldmann, 2005; 
Stangroom et al., 1998). The presence of persistent organic pollutants in wastewater, such as 
polyaromatic hydrocarbons, polychlorinated biphenyls, alkyl phenols, dioxins and furans, 
chlorinated solvents and benzene derivatives, has been long established (BGS et al., 1998; 
Rudel et al., 1998, among many others). 
The primary sources of pharmaceuticals in the environment are human excretion and disposal 
of unused products. Hospital waste water forms an important source for a range of EGCs 
including disinfectants and musks, as well as rare earth elements, heavy metals, and iodised 
contrast media (Putschew et al., 2000; Sacher et al., 2001; Ternes and Hirsch, 2000; Verlicchi 
et al., 2010; Watkinson et al., 2009). There are a large number of studies of WTW effluent 
and septic tanks (Clara et al., 2004; Drewes et al., 2003; Gasser et al., 2010; Glassmeyer et 
al., 2008; Heberer et al., 1997; Kreuzinger et al., 2004), of raw sewage (Sodré et al., 2009) 
and of artificial recharge using treated effluent (Cordy et al., 2004; Díaz-Cruz and Barceló, 
2008). Manufacturing sites may also contribute (Larsson, 2008; Larsson et al., 2007). There 
are about 9000 WTWs in the UK serving 95% of the population (Water UK, 2006). 
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The use of veterinary antibiotics in concentrated animal feeding operations is an important 
source of environmental contamination in the USA and parts of Europe and Asia (Bartelt-
Hunt et al., 2010). Veterinary antibiotics have been investigated in various environmental 
compartments including waste lagoons, groundwater below lagoons, as well as shallow 
groundwater from areas where animal waste had been applied to fields (Bartelt-Hunt et al., 
2010; Hu et al., 2010; Kim et al., 2011; Kolodziej et al., 2004; Sarmah et al., 2006; Watanabe 
et al., 2010; Watanabe et al., 2008). 
Landfill leachates contain large amounts of short and long-chain fatty acids, and can also 
contain caffeine, nicotine, phenols, sterols, PAH, chlorinated solvents and phthalates (Stuart 
and Klinck, 1998). The presence of pharmaceuticals in groundwater beneath or downgradient 
of a landfill has been confirmed by several authors (Ahel and Jelicic, 2001; Ahel et al., 1998; 
Eckel et al., 1993; Holm et al., 1995). Two recent studies (Barnes et al., 2004; Buszka et al., 
2009) investigating the occurrence of groundwater down gradient of landfills detected a range 
of industrial compounds (detergents, antioxidants, fire retardants, plasticisers) as well as 
PPCPs (antibiotics, anti-inflammatories, barbiturates) and the caffeine and the nicotine 
metabolite cotinine. 
3.3 Pathways 
For many EGCs the pathway from the source to the receptor is very unclear, since there is a 
paucity of information for most such novel contaminants. The pathway taken by a 
contaminant through the environment will depend upon its physicochemical properties, such 
as its solubility in water.  
Direct pathways for pharmaceuticals, urban and industrial contaminants to reach groundwater 
include leaking sewers, discharge of WWT effluent (directly to ground or to surface water 
which then infiltrates), landfill leachate, leaking storage tanks and other discharges to the 
ground that bypass the soil zone, such as septic tanks (Figure 1). Pathways to humans and 
groundwater from human and animal pharmaceuticals are set out by Boxall et al. (2002), 
Halling-Sørensen et al. (1998) and Jones et al. (2002). Verma et al. (2007) studied the 
behaviour of a pharmaceutical in surface and wetland waters.  
Contaminants applied to the soil surface will migrate through the soil zone, the unsaturated 
zone and the saturated zone in the well-established way. This may be the route for 
agricultural pesticides and components of sewage sludge.  The potential for organic 
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contaminants present in sewage sludge to leach following application to agricultural land was 
highlighted by Wilson et al. (1996), although in this study no problems were found using a 
screening exercise.  
Another important pathway is groundwater-surface water interaction. In many instances 
treated effluent from industrial premises and sewage works is discharged to surface water. 
This may then infiltrate to groundwater from losing reaches of rivers.  
In this review we have not highlighted the atmospheric transmission route as being 
significant but there may be mechanisms for non-volatile compounds to be mobilised. For 
example, Hamscher and Hartung (2008) suggest that dust may be a new route for veterinary 
compounds to enter the environment. 
3.4 Receptors 
Groundwater supplies about one third of public water supply in the UK rising to about 80% 
of public supply in the south and southeast of England. It also provides water for industry and 
irrigation, baseflow support to surface water and aquatic ecosystem health Under the Water 
Framework Directive (EC, 2000). Receptors, in terms of chemical status, include the 
groundwater body itself, drinking water abstractions, associated surface waters and directly 
dependent ecosystems. In parts of south east England, river baseflow from groundwater can 
be up to 90% of total flow. Receptors therefore can include human beings drinking tap water, 
other living creatures such as invertebrates and fish or the environment more widely.  
A clear connection between source terms of these contaminants as set out in section 3.2 and 
groundwater or its receptors is often not well defined enough for significant problems in 
groundwater to be anticipated. However the risks to such a valuable resource do need to be 
considered.   
4 Risk assessment for pesticides and their metabolites 
In order to assess the hazards presented by contaminants, information on usage, persistence, 
leachability and a robust sensitive analytical method is required. For many pesticides these 
requirements are fulfilled and an assessment of risk of leaching to groundwater can be made. 
However, the UK metaldehyde problem was not originally discovered due to lack of an 
analytical method and was exacerbated by recalcitrance to water treatment. For pesticide 
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metabolites this information can be sparse, and for other EGCs such as pharmaceuticals it can 
be lacking.  
4.1 Pesticides  
Pesticides can be synthetic chemical or natural substances and vary in their use, properties 
and potential impact on the environment. There are currently around 350 ingredients 
approved for use in agricultural pesticide products in the UK (BCPC and CABI, 2010).  
Agriculture and horticulture use nearly 80 per cent of all plant protection pesticides in 
England and Wales. There has been a trend towards more frequent treatments using complex 
tank mixes but using less persistent compounds and at an overall lower rate of application. 
Pesticides are also used to control weeds and pests in gardens and weeds on pavements and 
along railway lines. Pesticides used for seed dressings and biological pesticides were 
excluded from this study.  
Solubility and Kow can both give an indication of a compound’s mobility and likely sorption 
in water treatment.  Kow is commonly expressed as the log of the coefficient. It is used in 
environmental fate studies and large values (+4 or higher) are regarded as an indicator that a 
substance may tend to bioaccumulate. Conversely, low values indicate environmental 
mobility. Table 1 shows UK pesticides with the potential to persist in WTW effluent based on 
their Kow.  They may however, have other properties which are not assessed by this method; 
bipyridilium compounds such as diquat are cationic and form charge transfer complexes with 
organic matter (Gevao et al., 2000). Wells (2006) proposes Dow, a pH-dependent coefficient 
as a better measure of hydrophilicity.  
Pesticides most likely to pose a threat include those which remain difficult to analyse at low 
concentrations and also those in Table 1 which have the potential to persist in drinking water 
e.g. clopyralid.  
4.2 Pesticide metabolites 
Once released to the environment, pesticides may be degraded by both abiotic and biotic 
processes. While parent compounds are assessed in detail in many regulatory schemes, the 
requirements for the assessment of transformation products are less well developed. The 
potential issue of pesticide metabolites was highlighted by Kolpin et al. (2004) who found 
atrazine and metalochlor metabolite concentrations present in groundwaters at concentrations 
higher than the parent compounds. An initial assessment suggested that as many as 30% of 
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pesticide metabolites can be more toxic than the parent compound (Sinclair and Boxall, 
2003). Often their different properties can make them difficult to detect and quantify. 
Sinclair et al. (2010) reported measured metabolite concentrations in groundwater of the UK.  
These were all from compounds no longer licensed in the UK: DDT, heptachlor and atrazine.  
They also reported a desk study of impact on UK surface water derived drinking water based 
on potential to contaminate water for 53 pesticide metabolites based on parent compound 
usage, formation rates in soil, persistence and mobility, estimated toxicity and/or potential to 
exhibit pesticidal activity, the estimated efficiency of removal during drinking water 
treatment as well as during environmental degradation (Sinclair et al., 2010). This included 
compounds currently licensed and those which have recently been withdrawn, e.g. atrazine 
and isoproturon. About half of the compounds had been identified during environmental 
degradation as well as in mammalian toxicity testing of the parent. For five of the metabolites 
significant concentrations in surface water derived drinking water were predicted by their 
model. These were aldicarb sulphone (aldicarb metabolite), 3-carbamyl-1,2,4,5-
tetrachlorobenzoic acid (chlorothalonil metabolite), cyanazine chloroacid (cyanazine 
metabolite), desisopropyl atrazine and methomyl (thiodicarb metabolite and also parent 
compound).  
Parsons et al. (2008) carried out an assessment of risk from pesticide metabolites for both the 
US and the UK. For the UK, 54 pesticides were identified as representing 90% of all 
pesticide use. A risk index was used derived from an exposure index, depending on usage, 
fraction formed, water/organic carbon partition coefficient (Koc) and half life (DT50) together 
with acceptable daily intake. Compounds with the highest risk index were metabolites of 
cyanazine, followed by those of isoproturon, flufenacet, tebuconazole and dicamba. 
Table 2 summarises some European pesticide metabolite studies.  Other studies of pesticide 
metabolites in groundwater, have tended to be in areas where the suite of applications differs 
from that currently used in the UK (Chang and Liao, 2002; Fava et al., 2005; Giacomazzi and 
Cochet, 2004; Hancock et al., 2008; Hildebrandt et al., 2007; Kolpin et al., 2004; Montana 
Dept of Agriculture, 2006). 
Worrall et al. (2000) proposed using a probability index for predicting groundwater 
contamination risk using soil Koc and DT50 where points along a diagonal line have a similar 
estimated leaching probability. A simple assessment for pesticide metabolites for pesticides 
with UK usage >50,000 ha can be made using this method (Figure 2). Estimates of 
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persistence, physical properties and leachability data are available from the Footprint website 
(AERU, 2010) for some metabolites but these are much less comprehensive than for the 
parent compounds. The line shown is a cut-off between leachers and non-leachers. Values 
close to the line have been assessed as leachers. Compounds were assessed as non-leachers 
where Log Koc > 4 and Log DT50 <0.5. Key metabolites are shown in Table 3. This approach 
takes no account of the activity or toxicity of these metabolites and some of the metabolites 
may be trivial. 
The different approaches indicate that the metabolites of chlorothalonil, cyanazine, 
diflufenican, flufenacet, iodosulfuron-methyl, metaldehyde, metazachlor and metsulfuron-
methyl are likely to pose the greatest risk to drinking water. In many cases these metabolites 
are derived from parent compounds which have a lesser risk. 
Glyphosate is now the most widely used herbicide in the world, with dramatic increases in 
agricultural use since the introduction of glyphosate resistant crops.  Microbial degradation 
produces amino methyl phosphonic acid (AMPA) (Kolpin et al., 2000) and it has been 
anticipated that AMPA may be problematic.  The high water solubility of both the parent and 
the metabolite has meant that their analysis has been difficult. Kolpin (2006) showed AMPA 
to be detected in wastewater-impacted surface waters about four times as frequently as the 
glyphosate parent. Although AMPA has a DT50 of about 151 days and is therefore persistent 
it also has a relatively high Koc of 8087 mL/g and would not be classified as vulnerable to 
leaching by the simple method described above. Similarly for parent compounds which have 
non-agricultural applications, there will be routes to groundwater which would not be 
identified, such as routes which bypass the soil zone.  
5 Risk assessment for other emerging contaminants 
These include pharmaceuticals, personal care products, lifestyle compounds, and industrial 
compounds. Many of this group of compounds cannot as yet be assessed in the same way due 
to a lack of persistence data since the majority of studies have been directed at water 
treatment. There is a scarcity of data on human health effects at environmental levels, effects 
on aquatic organisms, and other harmful effects and therefore it is difficult to predict which 
health effects they may have on humans, terrestrial and aquatic organisms, and ecosystems. 
Studies often use a mixture of physical properties, degradation rates and monitoring case 
studies to reach an assessment. Many of these compounds are considered to be persistent in 
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the aqueous environment. However, it is characteristic of some contaminants  that they do not 
need to be persistent to cause negative effects since their high transformation/removal rates is 
compensated by their continuous introduction into the environment (EUGRIS, 2011).  
5.1 Attenuation in treatment works 
The effective operation of WTWs plays an important role in minimising the release of 
xenobiotic compounds into the aquatic environment (Byrns, 2001). A feature of some 
emerging contaminants is their recalcitrance to sewage treatment (Heberer, 2002b) or 
drinking water treatment which allows them to pass through into the treated water (Zwiener, 
2007).  
5.1.1 Wastewater treatment 
The first concerns regarding the potential adverse effects of pharmaceuticals in wastewater 
were expressed in the 1960s following a study of oestrogenic hormones in activated sludge 
(Stumm-Zollinger and Fair, 1965). A review of implications for the US water industry is 
provided by Snyder et al. (2003) starting from an analytical perspective. 
Joss et al. (2006) showed that efficiency of elimination of micro-organics depends on the 
relative rate of degradation and retention times in the plant. Maurer et al. (2007) showed that 
-blockers were incompletely removed in WTW due to both to limited sorption and 
degradation rates similar to the retention time. Many pharmaceuticals which pass through 
treatment may not be in the fully dissolved state and are often as glucuronaric acid or 
sulphate conjugates which enhances their polarity before excretion, and makes them harder to 
remove, but which can be cleaved during treatment to release further active ingredient 
(Ternes et al., 2004).  
Rosal et al. (2010) report a survey of over 70 individual pollutants in a WTW effluent using 
biological treatment followed by ozonation where several important groups of 
pharmaceuticals had typical removal efficiencies of <20%.  Ashton et al. (2004) suggested 
that most WTWs in England and Wales are likely to be routinely discharging small quantities 
(ng/L) of pharmaceuticals. A number of other studies have similar findings (Carballa et al., 
2004). A study in Sweden found diclofenac at higher concentrations in the effluent than in the 
influent (Zorita et al., 2009). 
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The oestrogenic effects of WTW effluent ascribed to ethinyl oestradiol and alkyl phenols 
have been recognised for two decades (Montagnani et al., 1996; Purdom et al., 1994). 
Rutishauser et al. (2004) showed that in-vitro tests were able to detect oestrogenic effects in 
effluents from these compounds and bisphenol A. An assessment of oestrogen removal 
efficiency for WTW in the UK (Johnson et al., 2007b) showed simple biological plants to be 
poor with only about 30% removal. Johnson and Williams (2004) were able to estimate the 
amount likely to be discharged using predictions of excretion fate and behaviour in the 
wastewater treatment system.  
Degradation of APEs in WTWs generates more persistent shorter-chain APEs and alkyl 
phenols such as NP, OP and alkylphenol mono- to tri-ethoxylates (Ying et al., 2002). The 
physicochemical properties of APE metabolites indicate that they will have a significant load 
in sediments and sludges. APE removal can be enhanced by GAC filtration, UV treatment or 
ozonolysis but these techniques do not resolve accumulation in sludge (Soares et al., 2008).   
Horii et al. (2007) showed that removal efficiencies for synthetic musks by WTWs ranged 
from 72% to 98% but concentrations of the galaxolide metabolite HHCB-lactone increased 
during treatment. Flame retardants may be present in effluent from WTWs accepting landfill 
leachate (Rahman et al., 2001). This may also be a route for other industrial compounds. 
Byrns (2001) showed that the effect of some operating parameters has an important influence 
upon the concentration of xenobiotics released in the sludges and final effluent. This may 
have significance for a wide range of ecotoxic compounds and in particular the class of 
compounds increasingly recognised as having the potential to disrupt endocrine activity in 
some aquatic invertebrates. 
5.1.2 Drinking water treatment 
For drinking water the main types of treatment processes relevant to micro-organics are: 
clarification/coagulation, granulated or powdered activated carbon (GAC or PAC) sorption, 
oxidation using ozone or chlorine and membrane filtration. In order to assess removal it is 
critical to understand their size distribution and particulate and colloidal association of micro 
contaminants in raw drinking water (Snyder et al., 2003). 
Filtration using GAC has been widely used to remove organic micropollutants from drinking 
water and is effective in removing emerging contaminants provided that it is correctly 
managed. Removal may be up to 90% for refractory compounds (Schäfer et al., 2002). Its 
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effectiveness is greatly reduced by the presence of natural organic matter which competes for 
binding sites, or particulates which block the pore spaces (Bolong et al., 2009; Snyder et al., 
2007). PAC is more efficient since it is fed as a new product and is not recycled through the 
treatment process whereas GAC can have a greater absorption capacity, particularly if steam 
treated, but needs regular replacement (Snyder et al., 2007). However, small and/or very 
polar molecules can be difficult to remove by this method. 
Membrane filtration, either by nanofiltration or reverse osmosis, has considerable potential to 
remove a wide range of emerging contaminants (Nghiem et al., 2005a; Nghiem et al., 2005b; 
Snyder et al., 2007). Membrane filtration can provide good removal except for lower 
molecular weight uncharged compounds (Snyder et al., 2007). Verliefde et al. (2007) 
assessed the application of nanofiltration to priority pollutant removal from water sources.  
Nanofiltration was particularly effective for negatively charged compounds (Zwiener, 2007). 
Membrane cleaning requires careful management (Nghiem and Schäfer, 2006). 
Chlorine and chlorine dioxide have been shown to be ineffective and also produced 
undesirable by-products (Zwiener, 2007).  Chlorine dioxide is anticipated to react particularly 
with compounds containing phenolic amino and thio functions (Snyder et al., 2003). In a 
study of 98 organic micro-compounds, Gibs et al. (2007) showed that 50% were not 
substantially degraded by combined and free chlorine. 
Reactions with ozone are reviewed by Snyder et al. (2003).  Advanced oxidation,  which uses 
a combination of ozone with other oxidation agents such as UV radiation, hydrogen peroxide 
or TiO2, generates reactive intermediates and includes electrochemical mineralisation and 
solar photocatalysis (Comninellis et al., 2008).  This is limited by the radical scavenging 
capacity of the matrix and can be expensive (Petrović et al., 2003).   
Ternes et al. (2002) investigated the elimination of selected pharmaceuticals (bezafibrate, 
clofibric acid, carbamazepine, diclofenac) during drinking water treatment processes at 
laboratory and pilot scale and in real waterworks. No significant removal of pharmaceuticals 
was observed in batch experiments with sand filtration under natural aerobic and anoxic 
conditions, thus indicating low sorption properties and high persistence with non-adapted 
microorganisms. Flocculation using iron(III) chloride in lab-scale experiments and 
investigations in waterworks exhibited no significant elimination. However, ozonation was in 
some cases very effective in eliminating the polar compounds diclofenac and carbamazepine 
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and reducing bezafibrate. Except for clofibric acid, GAC in pilot-scale experiments and 
waterworks provided a major elimination of the pharmaceuticals under investigation. 
Westerhoff et al. (2005) reviewed the effectiveness of a range of drinking water treatment 
processes for emerging contaminants on the laboratory scale. Aluminium sulphate and ferric 
chloride coagulants or chemical lime softening removed <25% of most emerging 
contaminants (ECs). PAC effectiveness was variable, from 10 to 90% depending on 
compound polarity (Kow). Ozone oxidized steroids containing phenolic moieties (oestradiol, 
ethinyloestradiol, or oestrone) more efficiently than those without aromatic or phenolic 
moieties (androstenedione, progesterone, and testosterone).  EC reactivity with oxidants were 
separated into three general groups:Ԝ (1) compounds easily oxidized (>80% reacted) by 
chlorine are always oxidized at least as efficiently by ozone; (2) 6 of the 60 compounds 
(TCEP, BHC, chlordane, dieldrin, heptachlor epoxide, musk ketone) were poorly oxidized 
(<20% reacted) by chlorine or ozone; (3) compounds (24 of 60) reacting preferentially 
(higher removals) with ozone rather than chlorine.  
In an overall assessment for 113 organic micro-compounds Stackelburg et al. (2007), 15% of 
the loading was removed by clarification, 32% by hypochlorite disinfection and 53% by GAC 
filtration. Compounds most frequently detected in finished water were carbamazepine, 
DEET, cotinine, tonalide, caffeine and camphor. 
The efficacy of drinking water treatment for pharmaceuticals was evaluated for GAC, 
oxidation and membrane filtration by Zweiner (2007).  A good correlation was found 
between the percentage removal by activated carbon and the octanol/water partition 
coefficient (Kow) for many compounds with log Kow >3. High rates of removal by ozonation 
are usually observed for compounds with double bonds, aromatic structure or heteroatoms, 
and this was the case for diclofenac, carbamazepine and sulfamethoxazole (Zwiener, 2007).  
Lower rates were observed for clofibric acid and ibuprofen which do not have reactive sites. 
These types of compounds are more readily degraded by advanced oxidation using, for 
example, the OH radical.  
Escher et al. (2009) assessed the efficiency of removal of toxicological activity by ozonation 
after secondary treatment using bioassays and compared that with removal using GAC. 
Escher et al. (2006) estimated the removal efficiency of pharmaceuticals and hormones in 
separated urine using both bioassays and chemical analysis. This approach was extended to 
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the ecotoxicological effects of polar micro-organics in effluent and receiving surface waters 
(Escher et al., 2008). 
In conclusion we can assume that there is potential for some EGCs to pass through drinking 
water treatment plants. Many such plants which treat groundwater may not have treatment 
which would remove these types of compounds as groundwater has a lower organic loading 
than surface water.  
5.2 Attenuation in the environment 
Physicochemical properties such as Kow are available for many of urban and industrial 
organic micropollutants from the SRC database (SRC, 2010). As a first pass estimate of 
recalcitrance to water treatment, of the compounds listed by Gibs et al. (2007), Stackelberg et 
al. (2007) and Glassmeyer et al. (2008), only 19 had a Kow of <1.  
Zweiner (2007) describes the processes which reduce the concentrations of pharmaceuticals 
in treated sewage effluent in the aqueous environment as biodegradation, sorption, photolysis 
and oxidation successively in surface water, bank filtration and drinking water treatment. 
Most degradation studies have been directed at degradation in surface water (Pal et al., 2010). 
Pal et al. (2010) also collated physicochemical properties reported in the literature for 14 
pharmaceuticals demonstrating their wide range. In general amines have higher sorption 
coefficients than carboxylic acids and neutral pharmaceuticals (Yamamoto et al., 2009).  Lai 
et al. (2000) showed that synthetic oestrogens were more readily removed from the aqueous 
phase in rivers and estuaries than natural compounds due to their higher Kow.  Sorption was to 
both organic carbon and iron oxides in sediments. 
Oppel et al. (2004) studied the leaching behaviour of 6 selected pharmaceuticals in different 
soils to simulate soil application. The results indicated that the leaching potential was low for 
diazepam, ibuprofen, ivermectin and carbamazepine, but clofibric acid and iopromide were 
very mobile under the experimental conditions.  
Drewes et al. (2003) showed that caffeine, gemfibrozil and many analgesics were removed 
from recharged treated effluent during groundwater recharge within six months, whereas 
carbamazepine and primidone persisted for up to 8 years. For a group of 8 pharmaceuticals 
Lam et al. (2004) showed that photolysis was much more significant than hydrolysis. Jürgens 
et al. (2002) measured the degradation of oestrodiol and ethinyl oestrodiol in English rivers 
and estimated a half-life of 10 days or less. Synthetic musks are assessed as being non-
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degradable with sorption and sedimentation being minor processes. Tonalide can be removed 
from surface water by direct photolysis but galaxolide shows negligible photochemical 
degradation (Buerge et al., 2003). 
Jones et al. (2002) made an environmental assessment for the 25 most-used prescription 
pharmaceuticals in the UK based on usage, removal in treatment works based on sorption and 
dilution.  Degradation was modelled due to lack of data and was predicted to be very limited 
for most compounds. Jones et al. (2005) assessed the potential for pharmaceuticals to enter 
the aqueous environment, reviewed the levels reported in drinking water world-wide and 
assessed the implications.  
Lindström et al. (2002) detected triclosan and its metabolite methyl triclosan in surface water 
in Switzerland and considered the metabolite to be persistent. 
Löffler et al. (2005) studied four 14C-labelled pharmaceuticals (diazepam, ibuprofen, 
iopromide, and acetaminophen) as well as six non-labelled compounds (carbamazepine, 
clofibric acid, 10,11-dihydroxycarbamazepine, 2-hydroxyibuprofen, ivermectin, and 
oxazepam) in batch studies of water/sediment. Ibuprofen, 2-hydroxyibuprofen, and 
paracetamol displayed a low persistence with DT50 values in the water/sediment system less 
<20 d and paracetamol was rapidly attenuated due to the extensive formation of bound 
residues. A moderate persistence was found for ivermectin, iopromide and oxazepam with 
DT50 values of <60 d. For diazepam, carbamazepine, 10,11-dihydroxycarbamazepine, and 
clofibric acid, system DT90 values of >365 days were found. An elevated level of sorption 
onto the sediment was observed for ivermectin, diazepam, oxazepam, and carbamazepine.  
Johnson et al. (2007a) applied an existing GIS model to predict the concentrations of the 
pharmaceuticals, diclofenac and propanalol, in surface water catchments. The model input 
parameters included consumption, excretion and fate. Concentrations predicted throughout 
the catchments were 1 ng/L under low flow except for downstream of small WTW where 
concentrations of up to 25 ng/L were predicted. 
Kavlock et al. (2008) reviews the types of model which can be used to estimate 
physicochemical properties and degradation mechanisms in the environment, and examples 
are shown in Table 4. 
The fate and transport of emerging contaminants in the aqueous environment remains poorly 
understood, particularly for groundwater. Established contaminants, such as pesticides, often 
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have persistence in groundwater of up to an order of magnitude longer than in soils and 
surface water.   
5.3 Toxicity 
5.3.1 Lifestyle and personal care products 
Pathways to humans will also include direct exposure through ingestion, inhalation or dermal 
contact and the risk posed by drinking water is likely to be considerably less. 
Caffeine and nicotine have been included in a number of studies of pharmaceutical fate (e.g. 
Debska et al., 2004; Santos et al., 2007; Schwab et al., 2005). Caffeine’s effect on the 
environment is not well understood, but does not appear to give cause for concern to 
freshwater organisms at currently detected concentrations (Moore et al., 2008). Nicotine has a 
high toxicity to humans, compared to other alkaloids and neonicotinoid pesticides, such as 
imidacloprid, are widely used. The toxicity of artificial sweeteners as food additives is 
reviewed by Grice and Goldsmith (2000) and by Whitehouse et al. (2008). 
DEET has been found to inhibit the activity of a central nervous system enzyme, 
acetylcholinesterase, in both insects and mammals (Corbel et al., 2009). Collated information 
on DEET in the aquatic environment suggested risk to aquatic biota at observed 
environmental concentrations is minimal.  
The parabens exert a weak oestrogenic activity (Oishi, 2002; Soni et al., 2002) and are 
capable of producing immunologically mediated, immediate systemic hypersensitivity 
reactions (Nagel et al., 1977). Some data on their environmental toxicity is now available 
(Bazin et al., 2010). Fatta-Kassinos et al. (2010) considered that  n-butyl and benzyl parabens 
should be classified as toxic substances whereas methyl, ethyl and n-propyl parabens are 
harmful. A synergistic oestrogenic effect was observed when other estrogenic compounds 
were also present. 
Triclosan is degraded to dioxins and is toxic to aquatic bacteria at levels found in the 
environment (Ricart et al., 2010). 
Work on toxicity of musks has mainly assumed a dermal exposure pathway (Ford et al., 
2000). They are degraded to more polar metabolites during treatment and in sediments and 
the soil. Heberer (2002a) discusses the results from investigations of synthetic musk 
concentrations found in sewage, sewage sludge, surface water, aquatic sediment, and biota 
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samples in terms of bioaccumulation, metabolism in fish, and environmental and human risk 
assessment. 
Many “lifestyle“ and PCPs which are commonly used may exhibit some toxic effects on 
humans or the environment. 
5.3.2 Industrial compounds 
The toxicological effects of many industrial compounds are long established; information is 
also available for many emerging compounds. 
Polybrominated diphenyl ether (PBDE) flame retardants have been found to bioaccumulate 
and have potential endocrine disrupting properties (Hooper and McDonald, 2000; Meerts et 
al., 2001; Rahman et al., 2001). Tris-(2-chloroethyl) phosphate (TRCP), which is used in 
industrial and consumer products, appears to be responsible for brain damage (Matthews et 
al., 1993).  There is relatively little information on PFOS toxicity (Hekster et al., 2003). 
Octyl and nonyl phenol have been long established as endocrine disruptors in fish (Petrović et 
al., 2004; White et al., 1994). The APEs can also be used as pesticide adjuvants. These can 
therefore be found in groundwater as a result of agricultural activity (Lacorte et al., 2002; 
Latorre et al., 2003). Thomas et al. (2001) used the toxicological impact of a storm event in 
an agricultural catchment near Tunbridge Wells to determine that significant components not 
being measured were present, and used this to identify the surfactant nonylphenol as well as 
the pesticides diuron, simazine endosulphan sulphate and pendimethalin.  
Both the water treatment by products NDMA and acrylamide affect the central nervous 
system and are carcinogenic (Smith and Oehme, 1991). 
Eljarrat and Barceló (2003) attempted to prioritize emerging and persistent organic pollutants 
in the environment based on their relative toxic potency. These included dioxins and 
polybrominated compounds. 
Carlsson et al. (2006) assessed 27 active ingredients, with 9 being identified as dangerous for 
the aquatic environment and only oestradiol and ethinyloestradiol considered to have possible 
aquatic environmental risks.  
Farré et al. (2008) review the fate and the ecotoxicology of emerging pollutants, especially 
focusing on their metabolites and transformation products (TPs) in the aquatic environment, 
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including pharmaceuticals, hormones, perfluorinated compounds, by-products of drinking-
water disinfection, sunscreens or UV filters, benzotriazoles and naphthalenic acids. 
Poynton and Vulpe (2009) applied an ecotoxicogenomic approach to assess the potential 
effects of a range of pharmaceuticals, endocrine disruptors, polybrominated flame retardants, 
perfluorinated compounds and nanomaterials. DNA-microarrays can be used to understand 
the effects of single compounds and mixtures, to suggest potential modes of action and 
predict exposure to pollutants in the environment.  
Schriks et al. (2010) derived provisional drinking water values for a selection of emerging 
contaminants based on toxicological literature data. Where no published values existed these 
were derived from the ADI or failing this from the LOEC/NOEC. These were compared with 
occurrence data for surface water of the Rhine and Meuse. This study identified 1,4-dioxane, 
benzene and NDMA as being found at the highest concentrations relative to the guidelines. 
PFOS and PFOA were also highlighted. For groundwater the highest concentrations were for 
the fuel-oxygenate methyl tertiary-butyl ether.  
5.4 Synergistic toxic effects 
Concern over the potential adverse health effects of groundwater contaminated by a cocktail 
of contaminants has existed for many years (Germolec et al., 1989).  The implications for 
mixtures of herbicides considered by WHO, who stated in 1987 that not these could not be 
handled in isolation (WHO, 1987).  Carpy et al. (2000) reviewed the possible effects of 
pesticide mixtures and Relyea (2009) showed how aquatic communities can be dramatically 
impacted by a cocktail of low concentrations of pesticides. Yang et al. (1989) describe the 
approaches to evaluating the toxicology of chemical mixtures. Seed et al. (1995) discuss the 
applicability and validity of the methods for the assessment of risk posed by exposure to 
environmentally relevant concentrations of chemical mixtures. Borgert et al. (2001) describe 
a set of criteria to: evaluate the quality of data and interpretations in chemical interaction 
studies said to reflect the consensus of the literature on interaction analysis which apply to 
interaction data for drugs, pesticides, industrial chemicals, food additives, and natural 
products. 
In a different approach Eljarrat and Barceló (2003) define a toxic equivalency factor (TEF) 
which provides a single number that is indicative of the overall toxicity in a mixture of 
related compounds. They used this for a mixture of dioxin and dioxin analogues. 
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Pomati et al. (2006; 2008) investigated the effects and interactions of a mixture of commonly 
used pharmaceuticals, including carbamazepine, ibuprofen and sulfamethoxazole at low 
concentrations, designed to mimic those found in the environment using in vitro tests on 
human and zebrafish cells. They concluded that a mixture of drugs at ng/L levels can inhibit 
cell proliferation by affecting their physiology and morphology and that waterborne 
pharmaceuticals may have an effect on aquatic life.  
Synergy remains an important topic with the complex mixtures of trace organic compounds 
being released to the environment. 
5.5 Risk assessment 
In their editorial to the special issue of Water Research ‘Emerging contaminants in water’ 
Ternes and von Gunten (2010) state that to elucidate the relevance of micropollutants in 
aquatic systems their (eco)toxicological potential must be addressed. Almost all studies of 
risk to the aquatic environment have been directed to surface water; risk assessment to 
humans from consumption of surface water has therefore been used as an analogue for 
groundwater accepting that groundwater itself may be less at risk from emerging 
contaminants. 
In an early review, Halling-Sørensen et al. (1998) collated concentrations of pharmaceuticals 
in the environment from human and veterinary use and also assessed their environmental fate 
and toxicity. They concluded that pharmaceuticals were present in the environment at 
concentrations similar to other xenobiotics, and highlighted the paucity of information.  
The principles of human risk assessment are set out by Lioy (1990) and these are illustrated  
using a flow diagram relating the  source of contaminant to health effects in humans. Risk 
assessments of pharmaceuticals in the aquatic environment use the comparison of predicted 
environmental concentration (PEC) and predicted no-effect concentration (PNEC) derived 
from the Acceptable Daily Intake (ADI). The process for registration of new drugs at the 
European level requires a risk assessment of the PEC using data on the volume of drug 
prescribed and the amount of dilution in the wastewater stream (EMEA, 2005). The method 
assumes “no biodegradation or retention of the drug substance in the WTW”.  This approach 
can also be used to assess existing compounds. Bound and Voulvoulis (2006) used the 
proportion of the population being treated, the dosage, the amount of wastewater generated 
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per day and an estimate of dilution to identify candidate compounds for a study of 
pharmaceuticals in UK rivers. 
Stuer-Lauridsen et al. (2000) calculated the PEC using the amount of compound used divided 
into the amount of wastewater generated both per capita diluted into the environment using a 
default value of 10, and estimating Kow and DT50 from literature values. They found limited 
ecotoxicity data to be available for calculation of PNEC and showed for the six compounds 
possible, PEC/PNEC>1 for ibuprofen, paracetamol and acetyl-salicylic acid. Webb (2000) 
made a similar assessment for drugs used in the UK in 1995. Of the 67 compounds assessed 
only 7 had PEC/PNEC>1 and only 11 had PEC/PNEC>0.1. 
Schwab et al. (2005) and Cunningham et al. (2009) presented human health risk assessments 
for a range of active pharmaceutical ingredients and/or their metabolites, representing 
different drug classes, using environmental monitoring data. ADIs were used to estimate 
PNECs for both drinking water and fish ingestion. The PNECs were compared to measured 
environmental concentrations (MECs) from the published literature and to maximum PECs 
generated using the regional assessment models PhATETM (Anderson et al., 2004) for North 
America and GREAT-ER (Feijtel et al., 1997) for Europe. The model predictions assumed 
low river flow and no depletion (no metabolism, no removal during wastewater or drinking 
water treatment, and no instream depletion). Ratios of MECs to PNECs were typically very 
low and consistent with PEC to PNEC ratios. For all 26 compounds, these low ratios indicate 
that no appreciable human health risk exists from the presence of trace concentrations in 
surface water and drinking water. 
Straub (2008) reviewed the derivation of PECs, PNECs and MECs for diazepam by both 
deterministic and probabilistic procedures and the probabilistic safety margin.  No significant 
concern was identified. In contrast, Cooper et al. (2008) ranked drugs by their potential 
environmental exposure and risk using annual prescriptions dispensed, surface water 
concentrations, effluent concentration, environmental half life, biological half life, mammal, 
fish and crustacean toxicity, Kow, solubility and ECOSAR (model used to estimate the aquatic 
toxicity of industrial chemicals). These were compiled into the PEIAR (Pharmaceuticals in 
the Environment, Information for Assessing Risk) database (CHBR, 2009). A preliminary 
assessment indicated that anti-infective, cardiovascular and central nervous system 
(analgesic, anti-inflammatory and psychotherapeutic) pharmaceuticals had the highest risks. 
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Toxicological and ecological assessments for pharmaceuticals are summarised by Pal et al. 
(2010). These used toxicity tests using freshwater invertebrates, fish, mussels and human 
embryonic cells. The sex hormones were viewed to be of the greatest concern, followed by 
cardiovascular drugs, antibiotics and anthineoplastics (chemotherapy drugs) (Sanderson et al., 
2004a). Currently, antibacterial resistance represents the most significant human health 
hazard, and potentially the largest non-target organism hazard is sex hormones acting as 
endocrine modulators in wildlife. 
In a study which did include groundwater, Schulman et al. (2002) assessed the risk to human 
health for 4 representative pharmaceuticals: acetylsalicylic acid, clofibrate, 
cyclophosphamide, and indomethacin which have been detected in aqueous environmental 
media including WTW effluent, surface water, drinking water, and groundwater. The 
toxicological and pharmacological nature, exposure assessment, and environmental fate and 
transport of each pharmaceutical were considered. The overall conclusion was that based on 
available data there was appreciable risk to humans, as the detected concentrations of each 
compounds were far below the derived safe limits. 
A number of studies have assessed the risk to aquatic organisms using species dependent 
criteria. Ferrari et al. (2003) calculated PNEC from bioassays for bacteria, algae, 
microcrustaceans, and fishes to perform an initial risk characterization against both MEC and 
PEC for carbamazepine, clofibric acid, and diclofenac. Only carbamazepine had a risk 
quotient >1. Sanderson et al. (2004b) ranked 2986 different pharmaceutical compounds in 51 
classes relative to hazard toward algae, daphnids, and fish using a quantitative structure-
activity relationship (QSAR) type model. Modifying additives were the most toxic classes. 
Cardiovascular, gastrointestinal, antiviral, anxiolytic sedatives hypnotics and antipsychotics, 
corticosteroid, and thyroid pharmaceuticals were the predicted most hazardous therapeutic 
classes.  
A review by Fent et al. (2006) found that only very little is known about long-term effects of 
pharmaceuticals to aquatic organisms, in particular with respect to biological targets. For 
investigated pharmaceuticals the chronic lowest observed effect concentrations (LOEC) in 
standard laboratory organisms are about two orders of magnitude higher than maximum 
concentrations in WTW effluents. For diclofenac, the LOEC for fish toxicity was in the range 
of wastewater concentrations, whereas the LOEC of propanolol and fluoxetine for 
zooplankton and benthic organisms were near to maximal effluent concentrations.  
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Kostich and Lazorchak (2008) used a simple approach, prioritising pharmaceuticals using 
marketing data and predicted concentrations of likely activity in wastewater to evaluate the 
risk to aquatic organisms using PECs. This approach was extended by comparison with 
regulatory data (Kostich et al., 2010).  
A preliminary risk assessment for a range of PCPs in surface water made by Brausch and 
Rand (2010), using both environmental fate data and toxicity to aquatic organisms, suggested 
that only triclosan and triclocarban presented any hazard but this did not take account of 
endocrine effects. 
Overall it is concluded that the sex hormones, PFOS and PFOA, diclofenac, carbamazepine 
and ibuprofen present the greatest risks to surface water, with possibly benzene and 1,4-
dioxane. However the risk assessment approaches available may not be adequate for the 
groundwater environment where inputs may not be the same and where environmental 
conditions controlling fate and transport may be very different from the surface.  
6 UK and European studies 
6.1 Surface water 
A possible indication of future groundwater contamination may be given by current surface 
water issues. It has long been recognised that the pollutant loading to surface waters is both 
temporally and spatially variable (Haith, 1985; Vega et al., 1998) although the risk and 
uncertainty can be modelled (Persson and Destouni, 2009). 
A summary of published work related to detection of organic micropollutants in UK surface 
waters is shown in Table 5. This demonstrates that a wide range of pharmaceuticals as well as 
industrial compounds and pesticides that have been detected.  Most of these studies have 
been associated with the impact of WTWs. It is well established that endocrine disruption in 
UK rivers is likely and due primarily to natural and synthetic oestrogens in sewage effluents 
(Johnson et al., 2007b). Mason et al. (1999) showed that point source contamination of 
surface water from pesticides was more significant than previously recognised.  
Loos et al. (2009) report an EU-wide reconnaissance of the occurrence of polar organic 
persistent pollutants in European river waters. Samples from over 100 rivers from 27 
European countries were analysed for 35 compounds, comprising pharmaceuticals, 
pesticides, PFOS, PFOA, benzotriazoles, hormones and endocrine disrupters. The compounds 
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detected most frequently and at the highest concentrations were benzotriazole, caffeine, 
carbamazepine, tolyltriazole and nonyl-phenoxy acetic acid. Only about 10% of the river 
water samples analysed could be classified as "very clean" in terms of chemical pollution. 
6.2 Groundwater 
Table 6 summarises European studies of organic micropollutants in groundwater. These 
confirm the detection of emerging contaminants such as ibuprofen, carbamazepine, 
diclofenac and sulfamethoxazole.    
Loos et al. (2010) report a pan-European reconnaissance for polar persistent organic 
pollutants in groundwater. In total, 164 individual groundwater samples from 23 European 
countries were collected and analysed (among others) for 59 selected organic compounds, 
comprising pharmaceuticals, antibiotics, pesticides (and their metabolites), perfluorinated 
acids (PFAs), benzotriazoles, hormones, alkylphenolics (endocrine disrupters), caffeine, 
DEET, and triclosan. 
Figure 3 shows the frequency of detection for compounds present in 20% or more of samples 
and the maximum concentrations detected by Loos et al. (2010). The most relevant 
compounds in terms of both frequency of detection and maximum concentrations detected 
were DEET, caffeine, PFOA, atrazine, desethylatrazine, 1H-benzotriazole 
methylbenzotriazole, desethylterbuthylazine, PFOS, simazine, carbamazepine, nonyl-
phenoxy acetic acid, bisphenol A, perfluorohexane sulfonate terbuthylazine, bentazone, 
propazine, perfluoroheptanoic acid, 2,4-dinitrophenol, diuron and sulfamethoxazole. 
In an investigation into the occurrence of perfluorinated compounds in groundwaters of 
England and Wales in 2006, perfluorinated compounds were detected in 26% (57 of 219) of 
groundwater monitoring sites, with detectable concentrations of PFOS found at about 14% of 
sites (Environment Agency, 2007; Environment Agency, 2008). 
Data from the Environment Agency’s monitoring programme for organic pollutants presented 
in this study indicates that within the 30 most frequently detected compounds are a number of 
emerging contaminants: atrazine metabolites, caffeine and DEET (Figure 4). Specific 
determinands with multiple detections include pesticides metabolites, pharmaceuticals 
including carbamazepine, triclosan, nicotine, food additives and alkyl phosphates (Table 7).  
This data set is not directly comparable with Loos (2010) since it contains non-polar 
compounds, fewer pesticides and perfluorinated compounds, has a different limit of detection 
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and is designed to capture compounds which do not form part of standard monitoring suites.  
Figure 5 shows the percentage detection for top 15 compounds from this study excluding 
hydrocarbons, PAH and chlorinated solvents compared with that reported for the same 
compounds by Loos et al. (2010).  
6.3 Comparison of river and groundwater concentrations 
These studies allow us to make a comparison between surface and groundwater. 
Concentrations of some contaminants are much higher in surface than groundwater as might 
be anticipated. For example, average concentrations of ibuprofen 100 times higher in rivers 
than groundwater, caffeine 75 times and carbamazepine 21 times.  PFOA, ketoprofen, 
sulfamethoxazole and oestrone are also relatively elevated in river water. 
However desethyl atrazine, bisphenol A, 4-octyl phenol are higher in groundwater. Clearly 
this could be related either to a different source and pathway of entry, but it could of course 
also be related to their different degradation rate in the subsurface. 
These data allow us to begin to identify important sources and routes to groundwater in the 
UK. The widespread detection of atrazine and its metabolites, and the recent problems with 
metaldehyde, show that diffuse sources such as agricultural and amenity pesticide use remain 
important. Pharmaceuticals, personal care products and lifestyle compounds are most likely 
to be derived from WTWs discharge either to the ground, or from sewer leakage, or through 
surface water/groundwater interaction. It is possible that some older compounds are the 
results of leakage from landfills which have received domestic or medical waste. PFOS and 
PFOA may have been released as the results of incidents such as fires and may both have 
infiltrated directly to groundwater or via surface water. We might conclude that all of the 
above routes need to be taken into account.  
It is clear that the risks to groundwater and its receptors are real.  Loos et al. (2010) report 
seemingly high concentrations of some compounds, but we as yet have insufficient data to be 
able to evaluate the significance of these findings. Many groundwater sources do not have 
treatment which would remove emerging contaminants and their lack of drinking water limits 
means that they are not currently being monitored. Much more research is needed to 
demonstrate whether emerging contaminants in river baseflow or groundwater dependent 
ecosystems are or could potentially have an impact. 
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7 Challenges in the management of emerging contaminants  
7.1 Identifying emerging contaminants 
The first challenge will be to identify the chemicals which potentially will become dangerous 
in the future and minimise the potential threat to groundwater, and to its receptors. To 
evaluate this threat the scientific community will need to: 
 identify possible new groundwater pollutants 
 identify possible new sources of such pollutants,  
 develop analytical methods to measure these compounds in a variety of matrices (e.g. 
water, sediment, waste) down to trace levels.  
 determine the environmental occurrence of these potential contaminants,  
 characterize the sources and source pathways that determine contaminant release to 
the aqueous environment,  
 identify possible new pathways for human exposure from contaminated groundwater, 
such as vapour intrusion. 
 define and quantify processes that determine their transport and fate through the 
environment, and  
 identify potential ecologic effects from exposure to these chemicals or 
microorganisms  
Daughton (2004) raises a number of issues relating to the management of emerging 
contaminant problems. 
 growing questions about pervasiveness and significance of low level effects, and 
awareness that there may be effects from concentrations below the toxic limit 
 issues that may occur from inadequate water infrastructure and decentralised water 
use  
 consequences of water reuse and artificial groundwater recharge 
 pollution prevention, early warning programmes, monitoring programmes, use of 
pollutants as indicators,  
 changing consumer behaviour and risk perception, communicating risk, new 
precautionary principles.  
These represent major challenges for both the science community and those with 
responsibilities for risk assessment and managing pollution.  
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7.2 Setting appropriate standards 
The Water Framework Directive (EC, 2000) and its Groundwater Daughter Directive  (EC, 
2006) require the setting of threshold values (TVs) for groundwater as part of the assessment 
of groundwater bodies. TVs have to be set for all pollutants which put the groundwater body 
at risk of failing to achieve good status. In setting TVs the following criteria must be 
considered: 
 extent of interaction of groundwater and ecosystems, 
 toxicology, dispersion tendency, persistence and bioaccumulation potential. 
For EGCs the establishment of TVs, if necessary, will be a challenging task and require much 
better understanding of key properties and their distribution and behaviour in groundwater. 
As such for individual compounds, this likely to be a lengthy process.  
Khadam and Kaluarachchi (2003) set out a multi-criteria decision analysis framework for 
environmental decision making in subsurface contamination remediation scenarios using 
probabilistic health risk assessment and economic analysis, in their case for carcinogenic 
impacts.  
The methodology uses the trade-off between:  
 population risk and individual risk by establishing a risk index  
 the residual risk and the cost of risk reduction by using cost per life saved as a 
criterion  
 cost-effectiveness as a justification for remediation.  
Three approaches to ranking the criteria for decision-making were explored: structured 
explicit decision analysis, a heuristic approach and fuzzy logic.  The results showed the 
importance of using an integrated approach for decision-making considering both costs and 
risks.  
A similar approach could be developed for establishing what levels of discharge controls and 
drinking water treatment would be appropriate to achieve an acceptable water quality at a 
realistic cost. An adaptation of the flowchart developed by Khadam and Kaluarachchi (2003) 
is shown in Figure 6. The pathway here could either be entry to the environment or migration 
in groundwater.   
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7.3 Reducing inputs 
There are a number of different areas which need to be tackled to reduce the overall input of 
emerging contaminants to groundwater. These include better handling and use, minimising 
waste product, correct disposal, reducing discharge to surface or groundwater and improved 
drinking water treatment.  
For example Kümmerer (2008) and Eckstein and Sherk (2011) set out a number of strategies 
for reducing PPCP and veterinary medicines in water resources through better control of the 
source term and minimising wastes, in addition to improved monitoring and regulating 
compounds entering water. These include:  
 product design – maintenance of effectiveness despite reduced dosage 
 delivery – more precise targeting and dosing, better delivery routes (e.g. transdermal), 
completion of course to reduce disposal 
 marketing  – guidance on disposal, broader range of package size, advertising 
 publication of environmental risk assessment data 
 dispensing  – expiry date, pharmacy inventories, database of both prescription and 
non-prescription drugs, reduction in availability of non-prescription drugs 
 restrictive prescription, and improvement in hygiene for farm animals  
 disposal/recycling – effective guidance, reverse distribution (take back programmes), 
recovery from wastewater 
 reduction of input by broken sewage/piping 
 separation of waste and rainwater to minimise necessary treatment  
 alternative products  – improved nutrition, probiotic products  
 demonstration of economic benefits of usage reduction by health insurers 
A major challenge in wastewater and drinking treatment is to improve existing processes and 
to design new ones to remove a large number of very different micropollutants in a range of 
matrices (Schwarzenbach et al., 2006). Future water treatments will require the development 
of more compact and efficient technologies. Existing strategies that predict relative removals 
of herbicides, pesticides, and other organic pollutants by activated carbon or oxidation can be 
directly applied for the removal of many ECs, but these strategies need to be modified to 
account for recalcitrant species (Westerhoff et al., 2005). Advanced oxidation and solar 
photocatalysis have the potential for further development (Comninellis, 2008; Robert and 
Malato, 2002). 
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7.4 Improved monitoring  
Techniques need to be sought to enable the wide range of potential new and existing 
contaminants to be detected in groundwater and surface water. These could include assays 
where the toxicological activity of the contaminant loading is measured rather than the 
identity of individual compounds. 
Targeted bioassays can be effective in assessing overall toxicological activity in effluents and 
surface water. Muller et al. (2007) have shown that combined passive sampling and a series 
of bioassays was effective in monitoring polar organics in effluents. 
Rodriguez-Mozaz et al. (2007) set out the advantages of using biosensors. These depend on 
recognition of antibodies, molecular sensors or DNA, or inference on enzyme functioning. 
These can be applied to pharmaceuticals and endocrine disruptors and have been applied to 
bisphenol A, oestrone, nonyl phenol, diethylstilbestrol, sulfamethazine, and tetracycline. 
Jardim et al. (in press) found that a yeast bioassay using a bioluminescent reported was more 
effective for monitoring for endocrine disruptors than analysis for the individual components.  
Bioassays can be sensitive, highly selective for compounds or activity, readily automatable 
and represent a cheap and fast way of screening for emerging contaminants.  
Biosensors are only one example of possible alternative approaches to monitoring EGCs in 
groundwater. Others which have been suggested are passive samplers (Alvarez et al., 2004; 
Stuer-Lauridsen, 2005; Vrana et al., 2001), although there are obvious 
difficulties/complexities in applying these cumulative sampling methods within a regulatory 
framework. 
8 Conclusions  
1. A wide range of organic micropollutants is now being detected in the aqueous 
environment world-wide. These include nanomaterials, pesticides, pharmaceuticals, 
industrial additives and by-products, personal care products and fragrances, water 
treatment by products, flame/fire retardants and surfactants, as well as caffeine and 
nicotine metabolites and hormones. Many of the compounds are relatively small 
and/or polar molecules which can often not be effectively removed by conventional 
drinking water treatment using activated carbon. Many of these compounds are also 
toxic or are classed as endocrine disruptors. 
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2. In order to assess the hazards presented by such compounds information on usage, 
persistence in soil and water, leachability and a robust and suitably sensitive 
analytical method is required. For many pesticides the above requirements are 
fulfilled and an assessment of risk of leaching to groundwater can be made. However, 
for pesticide metabolites this information can be sparse and for many emerging 
contaminants fate and transport data in the subsurface can be completely lacking with 
the  majority of persistence studies directed at water treatment.   A clear connection 
between source terms of these contaminants and groundwater-related receptors is 
often not well-defined to anticipate significant problems in groundwater.  For 
compounds with no regulatory limit in groundwater, risk assessments are generally 
made using a toxicological approach based on estimates of PEC and PNEC. 
Synergistic effects from mixtures of contaminants cannot yet be fully evaluated. 
3. A range of organic micropollutants from urban settings have been detected in 
European groundwater and surface water. Commonly detected compounds include: 
bisphenol A, caffeine, carbamazepine, DEET, galaxolide, ibuprofen, iopamidol, 
phthalates, phenyl ethoxylates, and sulfamethoxazole. Data presented in this study 
from the England and Wales Environment Agency’s monitoring programme for 
organic micropollutants indicates that within the 30 most frequently detected 
compounds are a number of emerging contaminants such as pesticide metabolites, 
caffeine and DEET. Specific determinands with multiple detections include pesticides 
metabolites, pharmaceuticals including carbamazepine and triclosan, nicotine, food 
additives and alkyl phosphates. 
4. Concentrations of some contaminants, such as ibuprofen and caffeine, are much 
higher in surface than groundwater but there are others, such as desethyl atrazine, 
which are higher in groundwater. This relates to different sources and pathways of 
entry, but it could of course also be related to different degradation rate in the 
subsurface. These data allow us to begin to identify important sources of emerging 
contaminants in groundwater in the UK; these include both diffuse sources and 
wastewater discharges. 
5. It is clear that the risks to groundwater and its receptors are real.  Many groundwater 
sources do not have treatment which would remove emerging contaminants and their 
lack of drinking water limits means that they are not currently being monitored. Much 
more research is needed to demonstrate whether emerging contaminants in river 
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baseflow or groundwater dependent ecosystems are or could potentially have an 
impact. 
6. Regulation of these compounds in groundwater and the wider environment will be a 
challenging task and require much better understanding of key contaminant properties 
and their distribution and behaviour in groundwater. The challenges include 
identifying new emerging compounds, setting appropriate standards, developing 
strategies to reducing inputs to the aqueous environment and applying novel 
monitoring methods.  
Acknowledgements 
This paper is published by permission of the Executive Director of the British Geological 
Survey. 
 
References 
Abe A. Distribution of 1,4-dioxane in relation to possible sources in the water environment. 
Sci Total Environ 1999;227:41-7. 
AERU. Pesticide Properties Database. Agriculture & Environment Research Unit, University 
of Hertfordshire, 2010. 
Ahel M, Jelicic I. Phenazone analgesics in soil and groundwater below a municipal solid 
waste landfill. In: Daughton CG, Jones-Lepp TL, editors. Pharmaceuticals and care 
products in the environment. 791. American Chemical Society, Washington DC, 2001, 
pp. 100-15. 
Ahel M, Mikac N, Cosovic B, Prohic E, Soukup V. The impact of contamination from a 
municipal solid waste landfill (Zagreb, Croatia) on underlying soil. Water Sci Technol 
1998;37:203-10. 
Ahrens L, Felitzeter S, Sturm R, Ebinghaus R. Polyfluorinated compounds in waste water 
treatment plant effluents and surface waters along the River Elbe, Germany. Mar Pollut 
Bull 2009;58:1326-33. 
36 
 
Alvarez DA, Petty JD, Huckins JN, Jones-Lepp TL, Getting DT, Goddard JP, et al. 
Development of a passive, in situ, integrative sampler for hydrophilic organic 
contaminants in aquatic environments. Environ Toxicol Chem 2004;23:1640-8. 
Anderson PD, D’Aco VJ, Shanahan P, Chapra SC, Buzby ME, Cunningham VL, et al. 
Screening analysis of human pharmaceutical compounds in US surface waters. Environ 
Sci Technol 2004;38:838-49. 
Ashton D, Hilton M, Thomas KV. Investigating the environmental transport of human 
pharmaceuticals to streams in the United Kingdom. Sci Total Environ 2004;333:167-84. 
Baran N, Lepiller M, Mouvet C. Agricultural diffuse pollution in a chalk aquifer (Trois 
Fontaines, France): Influence of pesticide properties and hydrodynamic constraints. J 
Hydrol 2008;358:56-69. 
Baran N, Mouvet C, Negrel P. Hydrodynamic and geochemical constraints on pesticide 
concentrations in the groundwater of an agricultural catchment (Brevilles, France). 
Environ Poll 2007;148:729-38. 
Baran N, Saplairoles M, Gourcy L, Denux J-P. Pesticide contamination of groundwater at the 
scale of a water body: example of the Ariège alluvial plain (France). European 
Groundwater Conference. Groundwater Protection in the EU, Madrid, 2010, pp. 77-83. 
Barnes KK, Christenson SC, Kolpin DW, Focazio MJ, Furlong ET, Zaugg SD, et al. 
Pharmaceuticals and other organic waste water contaminants within a leachate plume 
downgradient of a municipal landfill. Ground Water Monit R 2004;24:119-26. 
Barnes KK, Kolpin DW, Furlong ET, Zaugg SD, Meyer MT, Barber LB. A national 
reconnaissance of pharmaceuticals and other organic wastewater contaminants in the 
United States -- I) Groundwater. Sci Total Environ 2008;402:192-200. 
Bartelt-Hunt S, Snow DD, Damon-Powell T, Miesbach D. Occurrence of steroid hormones 
and antibiotics in shallow groundwater impacted by livestock waste control facilities. J 
Contam Hydrol 2010;123:94-103. 
Bazin I, Gadal A, Touraud E, Roig B. Hydroxy benzoate preservatives (parabens) in the 
environment: Data for environmental toxicity assessment. In: Fatta-Kassinos D, Bester K, 
Kümmerer K, editors. Xenobiotics in the urban water cycle. 16. Springer Netherlands, 
2010, pp. 245-57. 
37 
 
BCPC, CABI. The UK Pesticide Guide. Wallingford: CAB International & British Crop 
Protection Council, 2010. 
Bedding ND, McIntyre AE, Perry R, Lester JN. Organic contaminants in the aquatic 
environment I. Sources and occurrence. Sci Total Environ 1982;25:143-67. 
Bester K, Scholes L, Wahlberg C, McArdell C. Sources and Mass Flows of Xenobiotics in 
Urban Water Cycles—an Overview on Current Knowledge and Data Gaps. Water Air 
Soil Poll Focus 2008;8:407-23. 
BGS, CNA, SAPAL, WAJ, DMR, PSU. Protecting groundwater beneath wastewater recharge 
sites. British Geological Survey, Keyworth, 1998. 
Blackburn MA, Kirby SJ, Waldock MJ. Concentrations of alkyphenol polyethoxylates 
entering UK estuaries. Mar Pollut Bull 1999;38:109-18. 
Bolong N, Ismail AF, Salim MR, Matsuura T. A review of the effects of emerging 
contaminants in wastewater and options for their removal. Desalination 2009;239:229-46. 
Boorman GA. Drinking water disinfection byproducts: review and approach to toxicity 
evaluation. Environ Health Persp 1999;107:207-17. 
Borgert CJ, Price B, Wells CS, Simon GS. Evaluating chemical interaction studies for 
mixture risk assessment. Human  Ecol Risk Assess 2001;7:259-306. 
Bound JP, Voulvoulis N. Predicted and measured concentrations for selected pharmaceuticals 
in UK rivers: Implications for risk assessment. Water Res 2006;40:2885-92. 
Boxall ABA, Fogg LA, Blackwell PA, Kay P, Pemberton EJ. Review of veterinary medicines 
in the environment. Environment Agency Bristol, 2002. 
Brausch JM, Rand GM. A review of personal care products in the aquatic environment: 
Environmental concentrations and toxicity. Chemosphere 2010;82:1518-32. 
Bristol Water. Briefing on metaldehyde, 30/1/2009. 
Buerge IJ, Buser H-R, Kahle M, MuÌˆller MD, Poiger T. Ubiquitous occurrence of the 
artificial sweetener acesulfame in the aquatic environment: an ideal chemical marker of 
domestic wastewater in groundwater. Environ Sci Technol 2009;43:4381-5. 
Buerge IJ, Buser H-R, Muller MD, Poiger T. Behavior of the polycyclic musks HHCB and 
AHTN in lakes, two potential anthropogenic markers for domestic wastewater in surface 
waters. Environ Sci Technol 2003;37:5636-44. 
38 
 
Buerge IJ, Buser H-R, Poiger T, Müller MD. Occurrence and fate of the cytostatic drugs 
cyclophosphamide and ifosfamide in wastewater and surface waters Environ Sci Technol 
2006;40:7242-50. 
Buszka P, Yeskis D, Kolpin DW, Furlong E, Zaugg S, Meyer M. Waste-indicator and 
pharmaceutical compounds in landfill-leachate-affected ground water near Elkhart, 
Indiana, 2000–2002. Bull Environ Con Tox 2009;82:653-9. 
Buttiglieri G, Peschka M, Frömel T, Müller J, Malpei F, Seel P, et al. Environmental 
occurrence and degradation of the herbicide n-chloridazon. Water Res 2009;43:2865-73. 
Byrns G. The fate of xenobiotic organic compounds in wastewater treatment plants. Water 
Res 2001;35:2523-33. 
Carballa M, Omil F, Lema JM, Llompart M, García-Jares C, Rodríguez I, et al. Behavior of 
pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 
2004;38:2918-26. 
Carlsson C, Johansson A-K, Alvan G, Bergman K, Kühler T. Are pharmaceuticals potent 
environmental pollutants?: Part I: Environmental risk assessments of selected active 
pharmaceutical ingredients. Sci Total Environ 2006;364:67-87. 
Carpy SA, Kobel W, Doe J. Health risk of low-dose pesticide mixtures: A review of the 
1985-1998 literature on combination toxicology and health risk assessment. J Toxicol 
Env Heal B 2000;3:1-25. 
Chang SY, Liao C-H. Analysis of glyphosate, glufosinate and aminomethylphosphonic acid 
by capillary electrophoresis with indirect fluorescence detection. J Chromatogr A 
2002;959:309-15. 
CHBR. Pharmaceuticals in the environment, information for assessing risk Centre for Coastal 
and Environmental Health and Biomolecular Research Charleston, USA, 2009. 
Clara M, Strenn B, Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the 
aquatic environment: investigations on the behaviour of carbamazepine in wastewater 
treatment and during groundwater infiltration. Water Res 2004;38:947-54. 
Comninellis C, Kapalka A, Malato S, Parsons SA, Poulios I, Mantzavinos D. Advanced 
oxidation processes for water treatment: advances and trends for R&D. J Chem Technol  
Biotech 2008;83:769-76. 
39 
 
Cooper ER, Siewicki TC, Phillips K. Preliminary risk assessment database and risk ranking 
of pharmaceuticals in the environment. Sci Total Environ 2008;398:26-33. 
Corbel V, Stankiewicz M, Pennetier C, Fournier D, Stojan J, Girard E, et al. Evidence for 
inhibition of cholinesterases in insect and mammalian nervous systems by the insect 
repellent deet. BMC Biology 2009;7:47. 
Cordy GE, Duran NL, Bouwer H, Rice RC, Furlong ET, Zaugg SD, et al. Do 
pharmaceuticals, pathogens, and other organic waste water compounds persist when 
waste water Is used for recharge? Ground Water Monit R 2004;24:58-69. 
Cronin MTD, Walker JD, Jaworska JS, Comber MHI, Watts CD, Worth AP. Use of QSARs 
in international decision-making frameworks to predict ecologic effects and 
environmental fate of chemical substances. Environ Health Persp 2003;111:1376-90. 
Cunningham VL, Binks SP, Olson MJ. Human health risk assessment from the presence of 
human pharmaceuticals in the aquatic environment. Regul Toxicol Pharm 2009;53:39-45. 
Daughton CG. Non-regulated water contaminants: emerging research. Environ Impact Asses 
2004;24:711-32. 
Debska J, Kot-Wasik A, Namiesnik J. Fate and analysis of pharmaceutical residues in the 
aquatic environment. Crit Rev Anal Chem 2004;34:51-67. 
Díaz-Cruz MS, Barceló D. Trace organic chemicals contamination in ground water recharge. 
Chemosphere 2008;72:333-42. 
Drewes JE, Heberer T, Rauch T, Reddersen K. Fate of pharmaceuticals during ground water 
recharge. Ground Water Monit R 2003;23:64-72. 
EC. Drinking Water Directive 98/83/EC. European Commission, 1998. 
EC. Priority Substances Directive 2008/105/EC. European Commission, 2008. 
EC. Review of priority substances under the WFD, 2011. 
EC. Water Framework Directive 2000/60/EC. European Commission, 2000. 
Eckel WP, Ross B, Isensee RK. Pentobarbital found in ground water. Ground Water 
1993;31:801-4. 
40 
 
Eckstein G, Sherk GW. Alternative strategies for managing pharmaceutical and personal care 
products in water resources. Texas Tech University, Centre for Water Policy and Law, 
2011. 
Eljarrat E, Barceló D. Priority lists for persistent organic pollutants and emerging 
contaminants based on their relative toxic potency in environmental samples. TrAC-
Trend Anal Chem 2003;22:655-65. 
EMEA. Guideline on the environmental risk assessment of medicinal products for human 
use. European Medicines Agency London, 2005. 
ENDS. River dioxins increased by triclosan. ENDS Rep 2010;425:32. 
Environment Agency. Investigation of PFOS and other perfluorochemicals in groundwater 
and surface water in England and Wales. Environment Agency, Bristol, 2007. 
Environment Agency. Pesticides Report for 2007. Environment Agency, Bristol, 2008. 
Environment Agency. The Environment Agency’s position on Metaldehyde, Jan 2010. 
Escher BI, Bramaz N, Ort C. JEM Spotlight: Monitoring the treatment efficiency of a full 
scale ozonation on a sewage treatment plant with a mode-of-action based test battery. J 
Environ Monit 2009;11:1836-46. 
Escher BI, Bramaz N, Quayle P, Rutishauser S, Vermeirssen ELM. Monitoring of the 
ecotoxicological hazard potential by polar organic micropollutants in sewage treatment 
plants and surface waters using a mode-of-action based test battery. J  Environ Monit 
2008;10:622-31. 
Escher BI, Pronk W, Suter MJF, Maurer M. Monitoring the removal efficiency of 
pharmaceuticals and hormones in different treatment processes of source-separated urine 
with bioassays. Environ Sci Technol 2006;40:5095-101. 
EUGRIS. Portal for Soil and Water Management in Europe:- Emerging Pollutants. EUGRIS, 
2011. 
Farré Ml, Pérez S, Kantiani L, Barceló D. Fate and toxicity of emerging pollutants, their 
metabolites and transformation products in the aquatic environment. TrAC 2008;27:991-
1007. 
Fatta-Kassinos D, Bester K, Kümmerer K, Bazin I, Gadal A, Touraud E, et al. Hydroxy 
benzoate preservatives (parabens) in the environment: data for environmental toxicity 
41 
 
assessment. In: Fatta-Kassinos D, Bester K, Kümmerer K, editors. Xenobiotics in the 
urban water cycle. 16. Springer Netherlands, 2010, pp. 245-57. 
Fava L, Orru MA, Crobe A, Caracciolo AB, Bottoni P, Funari E. Pesticide metabolites as 
contaminants of groundwater resources: assessment of the leaching potential of 
endosulfan sulfate, 2,6-dichlorobenzoic acid, 3,4-dichloroaniline, 2.4-dichlorophenol and 
4-chloro-2-methylphenol. Microchem J 2005;79:207-11. 
Feijtel T, Boeije G, Matthies M, Young A, Morris G, Gandolfi C, et al. Development of a 
geography-referenced regional exposure assessment tool for European rivers—GREAT-
ER. Contribution to GREAT-ER # 1. Chemosphere 1997;34:2351-73. 
Fent K, Weston AA, Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 
2006;76:122-59. 
Ferrari B, Paxéus N, Giudice RL, Pollio A, Garric J. Ecotoxicological impact of 
pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and 
diclofenac. Ecotox Environ Safe 2003;55:359-70. 
Ford RA, Domeyer B, Easterday O, Maier K, Middleton J. Criteria for development of a 
database for safety evaluation of fragrance ingredients. Regul Toxicol Pharm 
2000;31:166-81. 
Fromme H, Otto T, Pilz K. Polycyclic musk fragrances in different environmental 
compartments in Berlin (Germany). Water Res 2001;35:121-8. 
Garrett P, Moreau M, Lowry J. MTBE as a ground water contaminant. NWWA/API 
Conference on Petroleum Hydrocarbons and Organic Chemicals in Ground Water: 
Prevention, Detection and Restoration. National Water Well Association, Dublin, Ohio, 
Houston, Texas, 1986, pp. 227-38. 
Gasser G, Rona M, Voloshenko A, Shelkov R, Tal N, Pankratov I, et al. Quantitative 
evaluation of tracers for quantification of wastewater contamination of potable water 
sources. Environ Sci Technol 2010;44:3919-25. 
Germolec DR, Yang RSH, Ackermann MF, Rosenthal GJ, Boorman GA, Blair P, et al. 
Toxicology studies of a chemical mixture of 25 groundwater contaminants : II. 
Immunosuppression in B6C3F1 mice. Fund Appl Toxicol 1989;13:377-87. 
42 
 
Gevao B, Semple KT, Jones KC. Bound pesticide residues in soils: a review. Environ Poll 
2000;108:3-14. 
Giacomazzi S, Cochet N. Environmental impact of diuron transformation: a review. 
Chemosphere 2004;56:1021-32. 
Gibs J, Stackelberg PE, Furlong ET, Meyer M, Zaugg SD, Lippincott RL. Persistence of 
pharmaceuticals and other organic compounds in chlorinated drinking water as a function 
of time. Sci Total Environ 2007;373:240-49. 
Giger G, Schaffner C, Kohler HP. Benzotriazole and tolyltriazole as aquatic contaminants. 1. 
Input and occurrence in rivers and lakes. Environ Sci Technol 2006;40:7186-92. 
Glassmeyer ST, Kolpin DW, Furlong E, Focazio MJ. Environmental presence and 
persistence of pharmaceuticals: an overview. In: Aga DS, editor. Fate of pharmaceuticals 
in the environment and in water treatment systems. CRC Press, Boca Raton, 2008, pp. 3-
52. 
Godfrey E, Woessner W, Benotti MJ. Pharmaceuticals in on-site sewage effluent and ground 
water, Western Montana. Ground Water 2007;45:263-71. 
Grice HC, Goldsmith LA. Sucralose--an overview of the toxicity data. Food Chem Toxicol 
2000;38:1-6. 
Haarstad K, Ludvigsen GH. Ten years of pesticide monitoring in Norwegian ground water. 
Ground Water Monit R 2007;27:75-89. 
Haith DA. Variability of pesticide loads to surface water. J Water Pollut Cont Fed 
1985;57:1062-67. 
Halling-Sørensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lützhøft HC, Jørgensen 
SE. Occurrence, fate and effects of pharmaceutical substances in the environment- A 
review. Chemosphere 1998;36:357-93. 
Hamscher G, Hartung J. Veterinary antibiotics in dust: sources, environmental 
concentrations, and possible health hazards. In: Kümmerer K, editor. Pharmaceuticals in 
the environment. Springer-Verlag, Berlin, 2008. 
Hancock TC, Sandstrom MW, Vogel JR, Webb RMT, Bayless ER, Barbash JE. Pesticide fate 
and transport throughout unsaturated zones in five agricultural settings, USA. J Environ 
Qual 2008;37:1086-100. 
43 
 
Harada K, Saito N, Sasaki K, Inoue K, Koizumi A. Perfluorooctane sulfonate contamination 
of drinking water in the Tama River, Japan: Estimated effects on resident serum levels. 
Bull Environ Con Tox 2003;71:31-6. 
Heberer T, Dünnbier U, Reilich C, Stan H-J. Detection of drugs and drug metabolites in 
ground water samples of a drinking water treatment plant Fresen Environ Bull 
1997;6:438-43. 
Heberer T, Feldmann D. Contribution of effluents from hospitals and private households to 
the total loads of diclofenac and carbamazepine in municipal sewage effluents--modeling 
versus measurements. J Hazard Mater 2005;122:211-8. 
Heberer T. Occurrence, fate, and assessment of polycyclic musk residues in the aquatic 
environment of urban areas — A review. Acta Hydroch Hydrob 2002a;30:227-43. 
Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic 
environment: a review of recent research data. Toxicol Lett 2002b;131:5-17. 
Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking 
water. J Hydrol 2002;266:175-89. 
Hekster FM, Laane RWPM, Voogt P. Environmental and toxicity effects of 
perfluoroalkylated substances. Rev Environ Contamin Toxicol 2003;179:99-121. 
Hilal SH, Bornander LL, Carreira LA. Hydration equilibrium constants of aldehydes, ketones 
and quinazolines. QSAR & Combin Sci 2005;24:631-38. 
Hildebrandt A, Lacorte S, Barcelo D. Assessment of priority pesticides, degradation products, 
and pesticide adjuvants in groundwaters and top soils from agricultural areas of the Ebro 
river basin. Anal Bioanal Chem 2007;387:1459-68. 
Hilton M, Thomas K, Ashton D. Targetted monitoring programme for pharmaceuticals in the 
aquatic environment. Environment Agency, Bristol, 2003. 
Holm JV, Rügge K, Bjerg PL, Christensen TH. Occurrence and distribution of 
pharmaceutical organic compounds in the groundwater downgradient of a landfill 
(Grindsted, Denmark). Environ Sci Technol 1995;29:1415-20. 
Hooper K, McDonald TA. The PBDEs: an emerging environmental challenge and another 
reason for breast-milk monitoring programs. Environ Health Persp 2000;108:387-92. 
44 
 
Horii Y, Reiner JL, Loganathan BG, Senthil Kumar K, Sajwan K, Kannan K. Occurrence and 
fate of polycyclic musks in wastewater treatment plants in Kentucky and Georgia, USA. 
Chemosphere 2007;68:2011-20. 
Hu X, Zhou Q, Luo Y. Occurrence and source analysis of typical veterinary antibiotics in 
manure, soil, vegetables and groundwater from organic vegetable bases, northern China. 
Environ Poll 2010;158:2992-8. 
Jackson R. Recognising emerging environmental problems: The case of chlorinated solvents 
in groundwater. Technol Cult 2004;45:55-79. 
Jacobsen CS, Sørensen SR, Juhler RK, Brűsch W, Aamand J. Emerging contaminants in 
Danish groundwater, 2005. 
Jardim WF, Montagner CC, Pescara IC, Umbuzeiro GA, Di Dea Bergamasco AM, Eldridge 
ML, et al. An integrated approach to evaluate emerging contaminants in drinking water. 
Separ Purific Technol in press. 
Jaworska J, Dimitrov S, Nikolova N, Mekenyan O. Probabilistic assessment of 
biodegradability based on metabolic pathways: CATABOL System. SAR QSAR  Environ 
Res 2002;13:307-323. 
Jeon H-K, Chung Y, Ryu J-C. Simultaneous determination of benzophenone-type UV filters 
in water and soil by gas chromatography-mass spectrometry. J Chromatogr A 
2006;1131:192-202. 
Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally 
persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. 
Environ Health Persp 1995;103:582-7. 
Johnson AC, Belfroid A, Di Corcia A. Estimating steroid oestrogen inputs into activated 
sludge treatment works and observations on their removal from the effluent. Sci Total 
Environ 2000;256:163-73. 
Johnson AC, Jürgens MD, Williams RJ, Kümmerer K, Kortenkamp A, Sumpter JP. Do 
cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and 
human health? An overview and UK case study. J Hydrol 2008;348:167-75. 
45 
 
Johnson AC, Keller V, Williams RJ, Young A. A practical demonstration in modelling 
diclofenac and propranolol river water concentrations using a GIS hydrology model in a 
rural UK catchment. Environ Poll 2007a;146:155-65. 
Johnson AC, Williams RJ, Simpson P, Kanda R. What difference might sewage treatment 
performance make to endocrine disruption in rivers? Environ Poll 2007b;147:194-202. 
Johnson AC, Williams RJ. A model to estimate influent and effluent concentrations of 
estradiol, estrone, and ethinylestradiol at sewage treatment works. Environ Sci Technol 
2004;38:3649-58. 
Jones OAH, Lester JN, Voulvoulis N. Pharmaceuticals: a threat to drinking water? Trends 
Biotechnol. 2005;23:163-7. 
Jones OAH, Voulvoulis N, Lester JN. Aquatic environmental assessment of the top 25 
English prescription pharmaceuticals. Water Res 2002;36:5013-22. 
Joss A, Zabczynski S, Göbel A, Hoffmann B, Löffler D, McArdell CS, et al. Biological 
degradation of pharmaceuticals in municipal wastewater treatment: Proposing a 
classification scheme. Water Research 2006;40:1686-96. 
Jürgens MD, Holthaus KIE, Johnson AC, Smith JJL, Hetheridge M, Williams RJ. The 
potential for estradiol and ethinylestradiol degradation in English rivers. Environ Toxicol 
Chem 2002;21:480-8. 
Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. The occurrence of pharmaceuticals, personal 
care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. 
Water Res 2008;42:3498-518. 
Kavanaugh MC. Unregulated and emerging chemical contaminants: technical and 
institutional challenges. P Water Environ Fed 2003;WEFTEC: Session 1-10:1-19. 
Kavlock RJ, Ankley G, Blancato J, Breen M, Conolly R, Dix D, et al. Computational 
toxicology - A state of the science mini review. Toxicol Sci 2008;103:14-27. 
Khadam IM, Kaluarachchi JJ. Multi-criteria decision analysis with probabilistic risk 
assessment for the management of contaminated ground water. Environ Impact Asses 
2003;23:683-721. 
46 
 
Kim K-R, Owens G, Kwon S-I, So K-H, Lee D-B, Ok YS. Occurrence and environmental 
fate of veterinary antibiotics in the terrestrial environment. Water Air Soil Poll 
2011;214:163-74. 
Kjaer, J, Olsen P, Henriksen T, Ullum M. Leaching of metribuzin metabolites and the 
associated contamination of a sandy Danish aquifer. Environ Sci Technol 2005;39:8374-
81. 
Kolodziej EP, Harter T, Sedlak DL. Dairy wastewater, aquaculture, and spawning fish as 
sources of steroid hormones in the aquatic environment. Environ Sci Technol 
2004;38:6377-84. 
Kolpin DW, Barbash JE, Gilliom RJ. Pesticides in ground water of the United States, 1992-
1996. Ground Water 2000;38:858-63. 
Kolpin DW, Schnoebelen DJ, Thurman EM. Degradates provide insight to spatial and 
temporal trends of herbicides in ground water. Ground Water 2004;42:601-8. 
Kolpin DW, Thurman EM, Linhart SM. The environmental occurrence of herbicides: The 
importance of degradates in ground water. Arch Environ Con Tox 1998;35:385-90. 
Kostich MS, Batt AL, Glassmeyer ST, Lazorchak JM. Predicting variability of aquatic 
concentrations of human pharmaceuticals. Sci Total Environ 2010;408:4504-10. 
Kostich MS, Lazorchak JM. Risks to aquatic organisms posed by human pharmaceutical use. 
Sci Total Environ 2008;389:329-39. 
Kreuzinger N, Clara M, Strenn B, Vogel JR. Investigation on the behaviour of selected 
pharmaceuticals in the groundwater after infiltration of treated wastewater. Water Sci 
Technol 2004;50:221-8. 
Kühne R, Ebert R-U, Schüürmann G. Estimation of compartmental half-lives of organic 
compounds – Structural similarity versus EPI-Suite. QSAR & Combin Sci 2007;26:542-
49. 
Kümmerer K. Strategies for reducing the input of pharmaceuticals into the environment. In: 
Kümmerer K, editor. Pharmaceuticals in the environment. Springer-Verlag, Berlin, 2008. 
Lacorte S, Latorre A, Guillamon M, Barcelo D. Nonylphenol, octylphenol, and bisphenol A 
in groundwaters as a result of agronomic practices. Sci World J 2002;2:1095-100. 
47 
 
Laganà A, Bacaloni A, De Leva I, Faberi A, Fago G, Marino A. Occurrence and 
determination of herbicides and their major transformation products in environmental 
waters. Anal Chim Acta 2002;462:187-98. 
Lai KM, Johnson KL, Scrimshaw MD, Lester JN. Binding of waterborne steroid estrogens to 
solid phases in river and estuarine systems. Environ Sci Technol 2000;34:3890-4. 
Lam M, Young C, Brain R, Johnson D, Hanson M, Wilson C, et al. Aquatic persistence of 
eight pharmaceuticals in a microcosm study. Environ Toxicol Chem 2004;23:1431-40. 
Lapworth DJ, Gooddy DC. Source and persistence of pesticides in a semi-confined chalk 
aquifer of southeast England, Environ Poll 2006;144: 1031–-44. 
Lapworth DJ, Baran N, Stuart ME, Lopez B, Ward RS. Emerging contaminants: a review of 
occurence, sources and fate in groundwater. Environ Poll submitted. 
Larsson DGJ, de Pedro C, Paxéus N. Effluent from drug manufactures contains extremely 
high levels of pharmaceuticals. J Hazard Mater 2007;148:751-5. 
Larsson DGJ. Drug production facilities - an overlooked discharge source for 
pharmaceuticals to the environment. In: Kümmerer K, editor. Pharmaceuticals in the 
environment. Springer-Verlag, Berlin, 2008. 
Latorre A, Lacorte S, Barceló D. Presence of nonylphenol, octyphenol and bisphenol a in two 
aquifers close to agricultural, industrial and urban areas. Chromatographia 2003;57:111-6. 
Lindström A, Buerge IJ, Poiger T, Bergqvist P-A, Müller MD, Buser H-R. Occurrence and 
environmental behavior of the bactericide triclosan and its methyl derivative in surface 
waters and in wastewater. Environ Sci Technol 2002;36:2322-9. 
Lioy PJ. Assessing total human exposure to contaminants. A multidisciplinary approach. 
Environ Sci Technol 1990;24:938-45. 
Liu Z-h, Kanjo Y, Mizutani S. A review of phytoestrogens: Their occurrence and fate in the 
environment. Water Res 2010;44:567-77. 
Löffler D, Römbke J, Meller M, Ternes T. Environmental fate of pharmaceuticals in 
water/sediment systems. Environ Sci Technol 2005;39:2509-18. 
Loos R, Gawlik BM, Locoro G, Rimaviciute E, Contini S, Bidoglio G. EU-wide survey of 
polar organic persistent pollutants in European river waters. Environ Poll 2009;157:561-
8. 
48 
 
Loos R, Locoro G, Comero S, Contini S, Schwesig D, Werres F, et al. Pan-European survey 
on the occurrence of selected polar organic persistent pollutants in ground water. Water 
Res 2010;44:4115-26. 
Mason PJ, Foster IDL, Carter AD, Walker A, Higginbotham S, Jones RL, et al. Relative 
importance of point source contamination of surface waters: River Cherwell catchment 
monitoring study. In: Del Re AAM, Brown C, Capri E, Errera G, Evans SP, Trevisan M, 
editors. Human and environmental exposure to xenobiotics. La Goliardica Pavese, Pavia, 
1999, pp. 405-12. 
Matthews HB, Eustis SL, Haseman J. Toxicity and carcinogenicity of chronic exposure to 
tris(2-chloroethyl)phosphate. Toxicol Sci 1993;20:477-85. 
Maurer M, Escher BI, Richle P, Schaffner C, Alder AC. Elimination of b-blockers in sewage 
treatment plants. Water Res 2007;41:1614-22. 
Meerts IA, Letcher RJ, Hoving S, Marsh G, Bergman A, Lemmen JG, et al. In vitro 
estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and 
polybrominated bisphenol A compounds. Environ Health Persp 2001;109:399-407. 
Mezcua M, Gómez MJ, Ferrer I, Aguera A, Hernando MD, Fernández-Alba AR. Evidence of 
2,7/2,8-dibenzodichloro-p-dioxin as a photodegradation product of triclosan in water and 
wastewater samples. Anal Chim Acta 2004;524:241-7. 
Miller KJ, Meek J. Helena Valley ground water: pharaceuticals, personal care products, 
endocrine disruptors (PPCPs) and microbial indicators of fecal contamination. Montana 
Bureau of Mines and Geology, 2006. 
Mitch WA, Sharp JO, Trussell RR, Valentine RL, Alvarez-Cohen L, Sedlak DL. N-
Nitrosodimethylamine (NDMA) as a drinking water contaminant: A review. Environ Eng 
Sci 2003;20:389-404. 
Moldovan Z. Occurrences of pharmaceutical and personal care products as micropollutants in 
rivers from Romania. Chemosphere 2006;64:1808-17. 
Montagnani DB, Puddefoot J, Davie TJA, Vinson GP. Environmentally persistent oestrogen-
like substances in UK river systems. Water Environ J 1996;10:399-406. 
Montana Dept of Agriculture. Groundwater monitoring for pesticides and nitrate in shallow 
aquifers of the Helena Valley, Montana, 2006. 
49 
 
Montgomery-Brown J, Reinhard M. Occurrence and behavior of alkylphenol polyethoxylates 
in the environment. Environ Eng Sci 2003;20:471-86. 
Moore M, Greenway S, Farris J, Guerra B. Assessing caffeine as an emerging environmental 
concern using conventional approaches. Arch Environ Con Tox 2008;54:31-5. 
Moran MJ, Zogorski JS, Squillace PJ. Chlorinated solvents in groundwater of the United 
States. Environ Sci Technol 2006;41:74-81. 
Moran MJ, Zogorski JS, Squillace PJ. MTBE and gasoline hydrocarbons in ground water of 
the United States. Ground Water 2005;43:615-27. 
Muller R, Tang JYM, Thier R, Mueller JF. Combining passive sampling and toxicity testing 
for evaluation of mixtures of polar organic chemicals in sewage treatment plant effluent. J 
Environ  Monit 2007;9:105-110. 
Musolff A, Leschik S, Möder M, Strauch G, Reinstorf F, Schirmer M. Temporal and spatial 
patterns of micropollutants in urban receiving waters. Environ Poll 2009;157:3069-77. 
Nagel JE, Fuscaldo JT, Fireman P. Paraben allergy. J Am Med Ass 1977;237:1594-5. 
Nghiem LD, Schäfer AI, Elimelech M. Nanofiltration of hormone mimicking trace organic 
contaminants. Separ Sci Technol 2005a;40:2633-2649. 
Nghiem LD, Schäfer AI, Elimelech M. Pharmaceutical retention mechanisms by 
nanofiltration membranes. Environ Sci Technol 2005b;39:7698-705. 
Nghiem LD, Schäfer AI. Critical risk points of nanofiltration and reverse osmosis processes 
in water recycling applications. Desalination 2006;187:303-12. 
Nikolaou A, Meric S, Fatta D. Occurrence patterns of pharmaceuticals in water and 
wastewater environments. Anal Bioanal Chem 2007;387:1225-34. 
Oishi S. Effects of propyl paraben on the male reproductive system. Food and Chemical 
Toxicology 2002;40:1807-13. 
Oppel J, Broll G, Löffler D, Meller M, Römbke J, Ternes T. Leaching behaviour of 
pharmaceuticals in soil-testing-systems: a part of an environmental risk assessment for 
groundwater protection. Sci Total Environ 2004;328:265-73. 
Osenbrück K, Gläser H-R, Knöller K, Weise SM, Möder M, Wennrich R, et al. Sources and 
transport of selected organic micropollutants in urban groundwater underlying the city of 
Halle (Saale), Germany. Water Res 2007;41:3259-70. 
50 
 
Pal A, Gin KY-H, Lin AY-C, Reinhard M. Impacts of emerging organic contaminants on 
freshwater resources: Review of recent occurrences, sources, fate and effects. Sci Total 
Environ 2010;408:6062-9. 
Parsons SA, Boxall ABA, Sinclair CJ, Ramwell C. Pesticide degradates of concern to the 
drinking water community. AWWA Research Foundation, Denver, 2008. 
Pérez S, Barceló D. Fate and occurrence of X-ray contrast media in the environment. Anal 
Bioanal Chem 2007;387:1235-46. 
Persson K, Destouni G. Propagation of water pollution uncertainty and risk from the 
subsurface to the surface water system of a catchment. J Hydrol 2009;377:434-44. 
Petrović M, Eljarrat E, Lopez de Alda MJ, Barceló D. Endocrine disrupting compounds and 
other emerging contaminants in the environment: A survey on new monitoring strategies 
and occurrence data. Anal Bioanal Chem 2004;378:549-62. 
Petrović M, Gonzalez S, Barceló  D. Analysis and removal of emerging contaminants in 
wastewater and drinking water. TrAC 2003;22:685-96. 
Pomati F, Castiglioni S, Zuccato E, Fanelli R, Vigetti D, Rossetti C, et al. Effects of a 
complex mixture of therapeutic drugs at environmental levels on human embryonic cells. 
Environ Sci Technol 2006;40:2442-7. 
Pomati F, Orlandi C, Clerici M, Luciani F, Zuccato E. Effects and interactions in an 
environmentally relevant mixture of pharmaceuticals. Toxicol Sci 2008;102:129-37. 
Power M, Attrill MJ, Thomas RM. Trends in agricultural pesticide (atrazine, lindane, 
simazine) concentrations in the Thames Estuary. Environ Poll 1999;104:31-9. 
Poynton HC, Vulpe CD. Ecotoxicogenomics: emerging technologies for emerging 
contaminants. J Am Water Resour As 2009;45:83-95. 
Purdom CE, Hardiman PA, Bye VVJ, Eno NC, Tyler CR, Sumpter JP. Estrogenic effects of 
effluents from sewage treatment works. Chem Ecol 1994;8:275-85. 
Putschew A, Wischnack S, Jekel M. Occurrence of triiodinated X-ray contrast agents in the 
aquatic environment. Sci Total Environ 2000;255:129-34. 
Rahman F, Langford KH, Scrimshaw MD, Lester JN. Polybrominated diphenyl ether (PBDE) 
flame retardants. Sci Total Environ 2001;275:1-17. 
51 
 
Relyea R. A cocktail of contaminants: how mixtures of pesticides at low concentrations affect 
aquatic communities. Oecologia 2009;159:363-76. 
Ricart M, Guasch H, Alberch M, Barceló D, Bonnineau C, Geiszinger A, et al. Triclosan 
persistence through wastewater treatment plants and its potential toxic effects on river 
biofilms. Aquat Toxicol 2010;100:346-53. 
Richardson ML, Bowron JM. The fate of pharmaceutical chemicals in the aquatic 
environment. J Pharm Pharmacol 1985;37:1-12. 
Richardson SD, Ternes TA. Water analysis: emerging contaminants and current issues. Anal 
Chem 2011;83:4614-4648. 
Richardson SD. Disinfection by-products and other emerging contaminants in drinking water. 
TrAC-Trend Anal Chem 2003;22:666-84. 
Richardson SD. Water analysis: emerging contaminants and current issues. Anal Chem 
2007;79:4295-324. 
Ritter L, Solomon K, Sibley P, Hall K, Keen P, Mattu G, et al. Sources, pathways, and 
relative risks of contaminants in surface water and groundwater: a perspective prepared 
for the Walkerton Inquiry. J Toxicol Env Heal A 2002;65:1 - 142. 
Robert D, Malato S. Solar photocatalysis: a clean process for water detoxification. Sci Total 
Environ 2002;291:85-97. 
Roberts PH, Thomas KV. The occurrence of selected pharmaceuticals in wastewater effluent 
and surface waters of the lower Tyne catchment. Sci Total Environ 2006;356:143-53. 
Rodriguez-Mozaz S, Lopez de Alda MJ, Barceló D. Advantages and limitations of on-line 
solid phase extraction coupled to liquid chromatography-mass spectrometry technologies 
versus biosensors for monitoring of emerging contaminants in water. J Chromatog A 
2007;1152:97-115. 
Rosal R, Rodríguez A, Perdigón-Melón JA, Petre A, García-Calvo E, Gómez MJ, et al. 
Occurrence of emerging pollutants in urban wastewater and their removal through 
biological treatment followed by ozonation. Water Res 2010;44:578-88. 
Rose CL, McKay WA, Ambidge PF. PCDD and PCDF levels in river systems in England 
and Wales, UK. Chemosphere 1994;29:1279-92. 
52 
 
Rudel RA, Melly SJ, Geno PW, Sun G, Brody JG. Identification of alkylphenols and other 
estrogenic phenolic compounds in wastewater, septage, and groundwater on Cape Cod, 
Massachusetts. Environ Sci Technol 1998;32:861-9. 
Rutishauser BV, Pesonen M, Escher BI, Ackermann GE, Aerni H-R, Suter MJF, et al. 
Comparative analysis of estrogenic activity in sewage treatment plant effluents involving 
three in vitro assays and chemical analysis of steroids. Environ Toxicol  Chem 
2004;23:857-64. 
Sabljic A. QSAR models for estimating properties of persistent organic pollutants required in 
evaluation of their environmental fate and risk. Chemosphere 2001;43:363-75. 
Sacher F, Lange FT, Brauch H-J, Blankenhorn I. Pharmaceuticals in groundwaters: 
Analytical methods and results of a monitoring program in Baden-Württemberg, 
Germany. J Chromatogr A 2001;938:199-210. 
Saito N, Sasaki K, Nakatome K, Harada K, Yoshinaga T, Koizumi A. Perfluorooctane 
sulfonate concentrations in surface water in Japan. Arch Environ Con Tox 2003;45:149-
58. 
Sanderson H, Brain RA, Johnson DJ, Wilson CJ, Solomon KR. Toxicity classification and 
evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular, 
and sex hormones. Toxicology 2004a;203:27-40. 
Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR. Ranking and 
prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol 
Pharm 2004b;39:158-83. 
Santos JL, Aparicio I, Alonso E. Occurrence and risk assessment of pharmaceutically active 
compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 
2007;33:596-601. 
Sarmah AK, Meyer MT, Boxall ABA. A global perspective on the use, sales, exposure 
pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. 
Chemosphere 2006;65:725-59. 
Schäfer AI, Nghiem LD, Waite TD. Removal of the natural hormone estrone from aqueous 
solutions using nanofiltration and reverse osmosis. Environ Sci Technol 2002;37:182-8. 
53 
 
Schriks M, Heringa MB, van der Kooi MME, de Voogt P, van Wezel AP. Toxicological 
relevance of emerging contaminants for drinking water quality. Water Res 2010;44:461-
76. 
Schulman LJ, Sargent EV, Naumann BD, Faria EC, Dolan DG, Wargo JP. A human health 
risk assessment of pharmaceuticals in the aquatic environment. Human  Ecol Risk Assess 
2002;8:657-80. 
Schwab BW, Hayes EP, Fiori JM, Mastrocco FJ, Roden NM, Cragin D, et al. Human 
pharmaceuticals in US surface waters: A human health risk assessment. Regul Toxicol 
Pharm 2005;42:296-312. 
Schwarzenbach RP, Escher BI, Fenner K, Hofstetter TB, Johnson CA, von Gunten U, et al. 
The challenge of micropollutants in aquatic systems. Science 2006;313:1072-7. 
Seed J, Brown RP, Olin SS, Foran JA. Chemical mixtures: current risk assessment 
methodologies and future directions. Regul Toxicol Pharm 1995;22:76-94. 
Seiler R, Zaugg SD, Thomas JM, Howcroft DL. Caffeine and pharmaceuticals as indicators 
of waste water contamination in wells. Ground Water 1999;37:405-10. 
Sinclair CJ, Boxall ABA. Assessing the ecotoxicity of pesticide transformation products. 
Environ Sci Technol 2003;37:4617-25. 
Sinclair CJ, van Beinum W, Adams C, Bevan R, Levy L, Parsons S, et al. A desk study on 
pesticide metabolites, degradation and reaction products to inform the Inspectorate's 
position on monitoring requirements. Final Report for Drinking Water Inspectorate. Food 
and Environment Research Agency, York, 2010. 
Singer AC, Nunn MA, Gould EA, Johnson AC. Potential risks associated with the proposed 
widespread use of Tamiflu. Environ Health Persp 2007;115:102-6. 
Smith EA, Oehme FW. Acrylamide and polyacrylamide: a review of production, use, 
environmental fate and neurotoxicity. Rev Environ Health 1991;9:215-28. 
Snyder SA, Adham S, Redding AM, Cannon FS, DeCarolis J, Oppenheimer J, et al. Role of 
membranes and activated carbon in the removal of endocrine disruptors and 
pharmaceuticals. Desalination 2007;202:156-81. 
54 
 
Snyder SA, Westerhoff P, Yoon Y, Sedlak DL. Pharmaceuticals, personal care products, and 
endocrine disruptors in water: Implications for the water industry. Environ Eng Sci 
2003;20:449-69. 
Soares A, Guieysse B, Jefferson B, Cartmell E, Lester JN. Nonylphenol in the environment: 
A critical review on occurrence, fate, toxicity and treatment in wastewaters. Environ Int 
2008;34:1033-49. 
Sodré F, Locatelli M, Jardim W. Occurrence of emerging contaminants in Brazilian drinking 
waters: A sewage-to-tap issue. Water Air Soil Poll 2009;206:57-67. 
Soni MG, Taylor SL, Greenberg NA, Burdock GA. Evaluation of the health aspects of 
methyl paraben: a review of the published literature. Food Chem Toxicol 2002;40:1335-
73. 
SRC. Interactive PhysProp database. SRC Inc, Syracuse, New York, 2010. 
Stackelberg PE, Gibs J, Furlong ET, Meyer MT, Zaugg SD, Lippincott RL. Efficiency of 
conventional drinking-water-treatment processes in removal of pharmaceuticals and other 
organic compounds Sci Total Environ 2007;377:255-72. 
Standley L, Rudel R, Swartz  C, Attfield K, Christian  J, Erickson M, et al. Wastewater-
contaminated groundwater as a source of endogenous hormones and pharmaceuticals to 
surface water ecosystems. Environ Toxicol Chem 2008;27:2457-68. 
Stangroom SJ, Collins CD, Lester JN. Sources of organic micropollutants to lowland rivers. 
Environ Technol 1998;19:643-66. 
Straub JO. Deterministic and probabilistic environmental risk assessment for diazepam. In: 
Kümmerer K, editor. Pharmaceuticals in the environment. Springer-Verlag, Berlin, 2008. 
Stuart ME, Klinck BA. A catalogue of leachate quality for selected landfills from newly 
industrialised countries. British Geological Survey Technical Report WC/98/49, 
Keyworth, 1998. 
Stuer-Lauridsen F. Review of passive accumulation devices for monitoring organic 
micropollutants in the aquatic environment. Environ Poll 2005;136:03-524. 
Stumm-Zollinger E, Fair GM. Biodegradation of steroid hormones. J Water Pollut Cont Fed 
1965;37:1506-10. 
55 
 
Teijon G, Candela L, Tamoh K, Molina-Díaz A, Fernández-Alba AR. Occurrence of 
emerging contaminants, priority substances (2008/105/CE) and heavy metals in treated 
wastewater and groundwater at Depurbaix facility (Barcelona, Spain). Sci Total Environ 
2010;408:3584-95. 
Ternes T, von Gunten U. Editorial to special issue in Water Research: Emerging 
contaminants in water. Water Res 2010;44:351. 
Ternes TA, Hirsch R. Occurrence and behavior of X-ray contrast media in sewage facilities 
and the aquatic environment. Environ Sci Technol 2000;34:2741-8. 
Ternes TA, Joss A, Siegrist H. Scrutinizing pharmaceuticals and personal care products in 
wastewater treatment. Environ Sci Technol 2004;38:392A-9A. 
Ternes TA, Meisenheimer M, McDowell D, Sacher F, Brauch H-J, Haist-Gulde B, et al. 
Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 
2002;36:3855-63. 
Thi PTP, Cho C-W, Yun Y-S. Environmental fate and toxicity of ionic liquids: A review. 
Water Res 2010;44:352-72. 
Thomas KV, Hurst MR, Matthiessen P, Sheahan D, Williams RJ. Toxicity characterisation of 
organic contaminants in stormwaters from an agricultural headwater stream in South East 
England. Water Res 2001;35:2411-6. 
US EPA. National Primary Drinking Water Regulations. United States Environmental 
Protection Agency, 2010. 
Van Stempvoort DR, Roy JW, Brown SJ, Bickerton G. Artificial sweeteners as potential 
tracers in groundwater in urban environments. J Hydrol 2011;401:126-33. 
Vega M, Pardo R, Barrado E, Debán L. Assessment of seasonal and polluting effects on the 
quality of river water by exploratory data analysis. Water Res 1998;32:3581-92. 
Verlicchi P, Galletti A, Petrovic M, Barceló D. Hospital effluents as a source of emerging 
pollutants: an overview of micropollutants and sustainable treatment options. J Hydrol 
2010;389:416-28. 
Verliefde A, Cornelissen E, Amy G, Van der Bruggen B, van Dijk H. Priority organic 
micropollutants in water sources in Flanders and the Netherlands and assessment of 
removal possibilities with nanofiltration. Environ Poll 2007;146:281-9. 
56 
 
Verma B, Headley JV, Robarts RD. Behaviour and fate of tetracycline in river and wetland 
waters on the Canadian Northern Great Plains. J Environ Sci Heal A 2007;42:109 -17. 
Voutsa D, Hartmann P, Schaffner C, Giger W. Benzotriazoles, alkylphenols and bisphenol A 
in municipal wastewaters and in the Glatt River, Switzerland. Environ Sci Pollut Res 
2006;13:333-41. 
Vrana B, Popp P, Paschke A, Schüürmann G. Membrane-enclosed sorptive coating. An 
integrative passive sampler for monitoring organic contaminants in water. Anal Chem 
2001;73:5191-5200. 
Vulliet E, Cren-Olivé C. Screening of pharmaceuticals and hormones at the regional scale, in 
surface and groundwaters intended to human consumption. Environ Poll 2011;159:2929-
34.Walker JD, Carlsen L, Hulzebos E, Simon-Hettich B. Global government applications 
of analogues, SARs and QSARs to predict aquatic toxicity, chemical or physical 
properties, environmental fate parameters and health effects of organic chemicals. SAR  
QSAR  Environ Res 2002;13:607-16. 
Watanabe N, Bergamaschi BA, Loftin KA, Meyer MT, Harter T. Use and environmental 
occurrence of antibiotics in freestall dairy farms with manured forage fields. Environ Sci 
Technol 2010;44:6591-600. 
Watanabe N, Harter TH, Bergamaschi BA. Environmental occurrence and shallow ground 
water detection of the antibiotic monensin from dairy farms. J Environ Qual 
2008;37:S78-S85. 
Water UK. Wastewater treatment and recycling. Water UK, London, 2006. 
http://www.water.org.uk/home/news/press-releases/wastewater-pamphlet/wastewater-
web--2-.pdf 
Water UK. Technical briefing note: metaldehyde. Water UK, London, 2009. 
Watkinson AJ, Murby EJ, Kolpin DW, Costanzo SD. The occurrence of antibiotics in an 
urban watershed: From wastewater to drinking water. Sci Total Environ 2009;407:2711-
23. 
Weil ED, Zhu W, Patel N, Mukhopadhyay SM. A systems approach to flame retardancy and 
comments on modes of action. Polym Degrad Stabil 1996;54:125-36. 
57 
 
Wells MJM. Log DOW: key to understanding and regulating wastewater-derived 
contaminants. Environ Chem 2006;3:439-49. 
Westerhoff P, Yoon Y, Snyder S, Wert E. Fate of endocrine-disruptor, pharmaceutical, and 
personal care product chemicals during simulated drinking water treatment processes. 
Environ Sci Technol 2005;39:6649-63. 
White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmentally persistent 
alkylphenolic compounds are estrogenic. Endocrinology 1994;135:175-182. 
Whitehouse  CR, Boullata J, McCauley LA. The potential toxicity of artificial sweeteners. 
AAOHN 2008;56:251-9. 
Whiteside TS, Hilal SH, Carreira LA. Estimation of phosphate ester hydrolysis rate constants. 
I. Alkaline hydrolysis. QSAR & Combin Sci 2006;25:123-33. 
WHO. Drinking Water Quality Guidelines for Selected Herbicides. Vol 27. Geneva: World 
Health Organisation, 1987. 
Williams GM, Harrison I, Carlick CA, Crowley O. Changes in enantiomeric fraction as 
evidence of natural attenuation of mecoprop in a limestone aquifer. J Contam Hydrol 
2003;64:253-67. 
Wilson SC, Duarte-Davidson R, Jones KC. Screening the environmental fate of organic 
contaminants in sewage sludges applied to agricultural soils: 1. The potential for 
downward movement to groundwaters. Sci Total Environ 1996;185:45-57. 
Worrall F, Wooff DA, Seheult AH, Coolen FPA. New approaches to assessing the risk of 
groundwater contamination by pesticides. Journal of the Geological Society 
2000;157:877-84. 
Yamamoto H, Nakamura Y, Moriguchi S, Nakamura Y, Honda Y, Tamura I, et al. 
Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: 
Laboratory photolysis, biodegradation, and sorption experiments. Water Res 
2009;43:351-62. 
Yang RSH, Hong HL, Boorman GA. Toxicology of chemical mixtures: experimental 
approaches, underlying concepts, and some results. Toxicol Lett 1989;49:183-97. 
Ying G-G, Williams B, Kookana R. Environmental fate of alkylphenols and alkylphenol 
ethoxylates--a review. Environ Int 2002;28:215-26. 
58 
 
Zhang Z, Hibberd A, Zhou JL. Analysis of emerging contaminants in sewage effluent and 
river water: Comparison between spot and passive sampling. Anal Chim Acta 
2008;607:37-44. 
Zorita S, Mårtensson L, Mathiasson L. Occurrence and removal of pharmaceuticals in a 
municipal sewage treatment system in the south of Sweden. Sci Total Environ 
2009;407:2760-70. 
Zuccato E, Castiglioni S, Bagnati R, Chiabrando C, Grassi P, Fanelli R. Illicit drugs, a novel 
group of environmental contaminants. Water Res 2008;42:961-8. 
Zwiener C. Occurrence and analysis of pharmaceuticals and their transformation products in 
drinking water treatment. Anal Bioanal Chem 2007;387:1159-62. 
  
59 
 
Table 1 Pesticides used in the UK over more than 50,000 ha in 2008 with octanol/water 
partition coefficients lower than metaldehyde 
Compound Log Kow 
Diquat -4.6
Mepiquat chloride -3.55
Chlormequat chloride -3.47
Glyphosate -3.2
Prohexadione-calcium -2.9
Clopyralid -2.63
Picloram -1.92
Dicamba -1.88
Metsulfuron-methyl -1.7
Thifensulfuron-methyl -1.7
Amidosulfuron -1.56
Quinmerac -1.41
Propamocarb hydrochloride -1.3
Florasulam -1.22
Imazaquin -1.09
2,4-D -0.83
MCPA -0.81
Mesosulfuron-methyl -0.48
Trinexapac-ethyl -0.29
MCPP-P 0.02
Metaldehyde 0.12
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Table 2 Summaries of selected studies finding pesticide metabolites in groundwater 
Area Pesticides detected Metabolites detected Process Ref erence 
Hesse, 
Germany 
Chloridazon desphenyl-chloridazon Parent and metabolite 
in STW effluent, 
surface water and 
groundwater 
Buttiglieri et al. 
(2009) 
Rome 
province, 
Italy 
2,4-D,  bentazone,  MCPA,  8-hydroxybentazone Survey Laganà et al. 
(2002) 
Lincolnshire, 
UK 
MCPP (chiral mixture) 4-chloro-2-methylphenol Change in enantiomeric 
ratio during degradation 
Williams et al. 
(2003) 
Kent, UK Diuron, Atrazine, Simazine DCPMU, DCPU, DCA Research project Lapworth and 
Gooddy (2006) 
Denmark Atrazine, bentazone, dichlorprop, 
MCPA, MCPP, simazine  
  
2,6-dichlorobenzamide (dichlobenil) 
deethylatrazine, deisopropylatrazine, 
hydroxyatrazine, ethylenethiurea 
(mancozeb), desamino-diketo- 
metribuzin, diketo- metribuzin,  
National monitoring 
programme 
Jacobsen et al. 
(2005) 
Denmark Metribuzin desamino-diketo- metribuzin, diketo- 
metribuzin 
Research project Kjaer et al.(2005) 
Norway 27 including bentazone, clopyralid, 
dichlorprop, dimethoate, isoproturon, 
linuron, mecoprop, metalaxyl, 
metribuzin, propachlor, terbutylazine 
desethyl atrazine, 2,6-
dichlorobenzamide, AMPA 
 
Monitoring Haarstad and 
Ludvigsen (2007) 
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France Atrazine, metolachlor desethyl-atrazine, ethane sulfonic acid, 
metolachlor oxanilic acid 
Catchment monitoring Baran et al. (2008; 
2007; 2010) 
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Table 3 Key metabolites assessed as having leaching potential from  Figure 2 
Parent compound Key metabolite DT50 Koc 
Chlorothalonil 
 
2-amido-3,5,6-trichlo-4-cyanobenzenesulphonic 
acid 
121 10 
3-carbamyl-2,4,5-trichlorobenzoic acid 103 77 
Cymoxanil 
 
2-cyano-2-methoxyiminoacetic acid 2.8 9 
3-ethyl-4-(methoxyamino)-2,5-dioxoimidazolidine-
4-carboxamide 
11.2 21.6 
Cyproconazole 1H-1,2,4-triazol-1-ylacetic acid 15 8 
Diflufenican 2-(3-trifluoromethylphenoxy)nicotinic acid 10.6 13 
Florasulam 
 
5-(aminosulfonyl)-1H-1,2,4-triazole-3-carboxylic 
acid 
328 83 
N-(2,6-difluorophenyl)-8-fluoro-5-
hydroxy[1,2,4]triazolo[1,5-c]pyrimidine-2-
sulfonamide 
23 21 
Flufenacet 
 
FOE oxalate 11 11 
FOE sulphonic acid 230 10 
Fluoxastrobin HEC-5725-des-chlorophenyl 67 60 
Fluroxypyr 4-amino-3,5-dichloro-6-fluoro-2-pyridinol 37 4 
Iodosulfuron-methyl- Na 2-amino-4-methoxy-6-methyl-1,3,5-triazine 181 97.7 
Mesosulfuron-methyl 4,6-dimethoxypyrimidine-2-yl-urea 48 3 
Mesosulfuron 53 68 
Metaldehyde Acetaldehyde 18.5 1.5 
Metsulfuron-methyl Saccharin 150 5.2 
Thiram N,N dimethyl carbamosulfonic acid 38 33 
Tribenuron-methyl 
 
N-methyl triazine amine 165 89 
Saccharin 105 5.2 
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Table 4 Examples of models to calculate properties required to predict the fate and transport 
of contaminants 
Model Description Parameters predicted Reference 
EPI-Suite Fragment constant KOW, solubility, 
hydrolysis rate 
(Kavlock et al., 
2008) 
KNN Atom-centred fragments indirect photolysis, 
biodegradation, and 
hydrolysis 
(Kühne et al.,2007) 
SPARC Fundamental chemical 
structure theory 
(LFER & PMO)  
Thermodyanamic 
properties 
Physicochemical 
properties 
(Hilal et al., 2005; 
Whiteside et al., 
2006) 
CATABOL Degradation simulator using 
hierarchy  of abiotic and 
enzymatic reactions 
Biotransformation 
pathways and 
metabolites 
(Jaworska et al., 
2002) 
SAR/QSAR  
type 
Molecular connectivity 
Structural activity relationship 
Physical and chemical 
properties, 
environmental fate, 
ecological effects and 
health effects of organic 
(Sabljic, 2001; 
Walker et al., 2002; 
Cronin et al., 2003) 
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Table 5 Organic micropollutants detected in UK surface water (LOD = limit of detection; TW = wastewater treatment works) 
Site Source Compounds detected Reference
England and Wales Contaminated 
& control  sites 
polychlorinated dibenzo-p-dioxins and dibenzofurans detected in all sediments sampled Rose et al. (1994) 
Thames in south west 
London and rural river 
WTW 
 
ibuprofen, paracetamol and salbutamol quantified in all samples. 
mefenamic acid (NSAID) in 70% of samples.  
propanolol (β-blocker) <LOD 
Bound and 
Voulvoulis (2006) 
Tyne Estuary WTW 
 
clotrimazole, dextropropoxyphene, erythromycin, ibuprofen, propanalol, tamoxifen, 
trimethoprim quantified 
clofibric acid, diclofenac, mefenamic acid, paracetamol <LOD 
Roberts and Thomas 
(2006) 
Tees, Mersey, Aire 
river and estuary 
Industry? APEs detected above threshold Blackburn et al. 
(1999) 
Taff & Ely, South 
Wales 
WTW 
 
trimethoprim, erythromycin, amoxicillin, paracetamol, tramadol, codeine, naproxen, 
ibuprofen, diclofenac, carbamazepine, gabapentin most frequently detected 
41 others detected including illicit drugs  
Kasprzyk-Hordern et 
al. (2008) 
Inland streams WTW 
 
ibuprofen, mefamic acid, diclofenac, propanalol, dextropropoxyphene, erythromycin, 
trimethoprim, acetyl-sulfamethazole detected 
paracetamol, lofepramine not detected  
Ashton et al. (2004) 
Ouse, west Sussex WTW 
 
bisphenol A, oestrone, 17β-oestodiol consistently detected
propanalol, sulfamethoxazole, carbamazepine, indomethacine, diclofenac variably detected 
mebeverine, thioridazine, tamoxifen, meclofenanic acid <LOD 
Zhang et al. (2008) 
UK  Diuron Alvarez et al. (2004) 
Stream, Tunbridge 
Wells 
Storm event, 
Fruit growing 
simazine, diuron, NP, endosulfan sulphate, pendimethalin Thomas et al. (2001) 
Thames, 1988-1997  atrazine, simazine, lindane Power et al. (1999) 
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Table 6 Summary of emerging contaminant detections in European groundwater 
Location Source Compounds detected (Range of concentrations (ng L-1)) Reference 
Eastern 
England 
STW Pharmaceuticals (<20-max):  Ibuprofen (5044), erythromycin (1022), dextropropoxyphene (682), diclofenac 
(568), mefanamic acid (366), propanolol (215), acetyl-sulfamethoxazole (239), trimethoprim (42) 
Hilton et al. 
(2003) 
Berlin, 
Germany 
STW Pharmaceuticals (0-mean): clofibric acid (7300), clofibric acid derivative (2900), propyphenazone (1465), 
phenazone (1250), salicylic acid (1225),  primidone (690), genistic acid (540), N-methylphenacetin (470), 
diclofenac (380), gemfibrozil (340), ibuprofen (200), fenofibrate (45), ketoprofen (30).  
Heberer  (2002) 
Leipzig, 
Germany  
STW Bisphenol A (~7000), NP (~1000), caffeine (~140), carbamazepine (~90), tonalide (~6), galoxalide (~2.8) Musolff et 
al.(2009)  
Halle, 
Germany 
STW Bisphenol A(<1-1136), carbamazepine (<2-83), galaxolide (3-19) Osenbrück et al. 
(2007)   
Baden-
Würtemberg, 
Germany 
STW Maximum concentrations:  amidotrizoic acid (1100), carbamazepine (900), diclofenac (590), sotalol (560), 
sulfamethoxazole (410), iopamidol (300), anhydro-erythromycin (49), phenazone (25). 
Sacher et al. 
(2001) 
France Regional 
survey 
Hormones (0.4 to 4): levonorgestrel (4), progesterone (1.6), testosterone (1.4); Pharmaceuticals (0 to 14): 
oxazepam (14), carbamazepine (10.4), acetaminophen (10.3), metformin (9.9), diclofenac (9.7), salicylic acid 
(metabolite) (6.5), atenolol (5.5), sulfamethoxazole (3). 
Vulliet and Cren-
Olivé (2011) 
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Table 7 Data from UK Environment Agency Monitoring for compounds with >20 detections in groundwater  over the period 1992 to 2009 
Type Name Detects Sites Max conc (µg/L) Use 
Pharmaceuticals and 
personal care products 
DEET 280 280 6.5 Insect repellent 
Propylparaben 68 68 5.5 Personal care 
Methylparaben 44 44 5 Personal care 
Trimipramine 34 34 0.26 Antidepressant 
Carbamazepine 32 32 3.6 Antiepileptic 
Oxybenzone 32 32 70.4 Personal care 
1,3-Dicyclohexylurea 27 27 0.41 Blood pressure/hypertension 
Isopropyl myristate 22 22 0.39 Personal care 
Triclosan 22 22 2.11 Antibacterial 
Coumarin 20 20 0.42 Anticoagulant 
Lifestyle and food 
additives 
Caffeine 722 720 4.5 Coffee and tea 
Nicotine 107 107 8.07 Tobacco  ingredient 
2,6-di-t-butyl-4-methylphenol (BHT) 106 106 7.0 Food additive 
2,6-di(t-butyl)-4-hydroxy-4-methyl-2,5-
cyclohexadien-1-one (BHT analogue) 
79 79 4.2 Food additive 
1(3H)-Isobenzofuranone (phthalide) 59 56 9.3 Food additive 
Cotinine 40 40 0.4 Nicotine metabolite 
Vanillin 31 31 1.08 Food additive 
p-acetylacetophenone 30 30 9.42 Food additive 
Dimethyldisufide 22 22 9.48 Food additive 
Alkyl phosphates and 
resins 
Tributylphosphate 450 450 2.5 Solvent, plasticiser & anti-foaming 
Bisphenol A 209 206 9.3 Resin precursor 
2-ethylhexyl diphenyl phosphate 68 68 2.7 Flame retardant plasticiser 
Tris(2-dichloroethyl)phosphate 54 54 4.9 Flame retardant plasticiser 
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Figure 1Sources (bold) and pathways for emerging contaminants to reach various receptors (grey) 
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Figure 2 Classification of leaching probability of all compounds using Koc and DT50 (after 
Worrall et al, 2000).  Compounds with solid symbols assessed as leachers 
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Figure 3 Frequency of detection and maximum detected concentrations in European 
groundwater (from Loos et al., 2010) 
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Figure 4 The top 30 most frequently detected compounds in the Environment Agency 
groundwater organic micropollutant database (DEET = N.N-dimethyl-toluamide, BBSA = N-butyl 
benzene sulphonamide) 
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Figure 5 Top 15 polar compounds detected in England and Wales groundwater from this 
study compared with Loos et al 2010 
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Figure 6 Flow chart showing risk-based decision analysis (adapted from Khadam and 
Kaluarachchi, 2003) 
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